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INTRODUCTION 
Murine Major Histocompatibility Complex 
Peter Gorer was the first to demonstrate that there are a series of 
blood group antigens which control tissue graft rejection (Gorer, 1936; 
1937; 1938). Using serological methods, Gorer was able to determine that 
one of these antigens was an alloantigen (designated antigen II) and that 
when a graft from an inbred mouse, with one set of alloantigens was trans­
planted to an inbred mouse with a different set of alloantigens, the graft 
was rejected. In 1948, Gorer and George Snell showed that the genes cod­
ing for alloantigens responsible for graft rejection were on linkage group 
IX of the mouse genome (Gorer et al., 1948), now known as chromosome 17. 
Gorer and Snell thought they were dealing with a single gene and named 
this gene the H-2 locus. Further research has revealed that the H-2 locus 
is really a complex of genes and the murine major histocompatibility com­
plex (MHC) is now known as the H-2 complex. (The human MHC is the HLA 
complex.) 
The H-2 complex is located at a distance of 15 cM from the centromere 
of chromosome 17 (Klein, 1975). It is between 1 and 2 cM in length, con­
taining 2000-4000 kb of DNA (see Figure la; Hood et al., 1983). The com­
plex codes for three classes of proteins, designated I, II, and III. The 
class I molecules are cell surface molecules and are divided into two 
categories; those encoded in the K, 2* and I. regions, and those encoded in 
the Q/TL region. The JÇ, D, and L encoded molecules are known as trans­
plantation antigens and are the mediators of graft rejection and cell 
interactions in the immune response. Transplantation antigens are found 
on all nucleated cells of the mouse. The class I molecules of the Q/TL 
region are structurally related to those of the K, D, and I. regions, but 
are limited in their tissue distribution and appear to have different 
functions than the K, D, and L antigens (Flaherty, 1980). The protein 
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Figure la. Genetic map of the murine MHC. The 5 regions encoding the HHC antigens are shown» as 
well as some of the genes within the regions. All of the Individual genes of the K, D 
and q/TL regions are not shown. The class of protein encoded in each region is shown. 
The number of genes in the BIO mouse strain (H-2^) (Weiss et al.» 1984), and BALB/c 
mouse strain (H-2^) (Minoto et al., 1983), the two best-studied strains to date, are 
shown. This figure was adapted from Mellor (1986) 
Figure lb. Schematic linear DNA maps showing the organization of class I genes from BIO (top lines) 
and BAlB/c (bottom lines) mouse strains. Arrows above the thick bars (genes) indicate 
the 5' to 3' orientation of genes. The scale In kllobase pairs (kbp) Is Indicated. 
BALB/c class I gene clusters are lined up below the corresponding region of BIO DNA 
where possible. Gene 6" of cluster 1 of the BALB/c genome corresponds to a pseudogene, 
27.1. The figure Is adapted from Mellor (1986) 
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Figure Ic. Schematic linear DNA maps showing BALB/c class I gene 
clusters which have no obvious structural counterparts in 
BIO DNA. This figure was adapted from Mellor (1986). Qa in 
cluster 6 marks the putative location in the BALB/c strain 
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structure, gene structure and function of the class I molecules will be 
discussed in detail in the next section. 
The class II molecules, designated A^, Ag, and Eg are cell surface 
molecules encoded in the X region of the H-2 complex (see Figure la). 
These molecules constitute the la antigens which control the magnitude of 
the immune response (reviewed in Kaufman et al., 1984). The class II 
antigens are made up of two noncovalently associated polypeptide chains, a 
and g. The a chain has a molecular weight of 30,000 to 33,000 daltons and 
contains sites at which two carbohydrates are attached. The g chain has a 
molecular weight of 27,000-29,000 daltons and contains a single carbo­
hydrate attachment site. Each chain is synthesized independently in the 
cytoplasm but form into the heterodimers I-A (A^zAg) and I-E (E^^iEg) prior 
to their insertion in the plasma membrane. 
Historically, serological and functional assays on recombinant mice 
divided the 2 region into 5 separate subregions (reviewed by Klein et al., 
1981; 1983): I-A, I-B, I-E, I-J and I-C. However, molecular analysis at 
the DNA level has revealed that only the I-A and I-E antigens are chemi­
cally defined. The Ag, A^^, and E^ molecules are encoded in the I-A sub-
region while the Eg molecule is encoded in the I-E subregion. The I-J 
subregion has been shown to be located on chromosome 4 and not on chromo­
some 17 at all (Hayes et al., 1984), although this location has recently 
been question by Waltenbaugh et al. (1985). 
The 2 region of the BALB/c mouse strain has been characterized using 
human class II cDNA probes and chromosome walking (Steinmetz et al., 1982; 
Hood et al., 1983; Steinmetz et al., 1984; and Steinmetz, 1985). A con­
tiguous stretch of 300 kb of DNA has been isolated (Steinmetz et al., 
1984), which contains the 4 known class II genes, A^, Ag, E^^, and Eg. The 
region also contains two additional g genes, Ag2 and Eg2 (Steinmetz et 
al., 1981b). Recently, another class II g gene, Agg, was described and 
• 
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shown by sequence analysis to be a pseudogene (Widera and Flavell, 1985). 
It is unknown if Ag2 and Agg are functional genes. Wake and Flavell 
(1985) have shown that the Ag2 gene is transcribed in the spleen and its 
mRNA has been found on membrane bound polysomes, suggesting that it is 
translated. Analysis of nine independently derived recombinant mouse 
strains has shown that the region around the Eg gene contains a hot spot 
for recombination (Steinmetz et al., 1982). This region is at most 8kb of 
DMA in length. The organization and orientation of the class II genes 
indicate that the gene complex has been generated by a duplication of an 
a-g-6 unit during evolution (Steinmetz, 1985). 
Class II molecules function primarily in the commun1cation between 
cells that regulate the Immune response. The antigens serve as re­
stricting elements for T helper and T supressor cells. They are not as 
widespread in their tissue distribution as class I molecules; class II 
molecules are expressed on lymph node and spleen lymphocytes, macrophages, 
fetal liver cells, epidermal cells, some marrow cells and spermatazoa 
(Mol1er, 1976). 
Three components of complement, C2, C4 and factor B, are encoded by 
genes in the ^ region of the H-2 complex. Together with the sex limited 
protein (Sip), these molecules make up the third class of proteins found 
in the MHC, the class III proteins (see Figure la). In addition, several 
groups have reported mapping a control protein, C4 binding protein, C4bp, 
to a region between the H-2D and the ^ regions (Kaido et al., 1981; 
Takahashi et al., 1984), but this has not been confirmed by others 
(Rodriguez de Cordoba et al., 1985). The class III genes are expressed 
primarily in the liver and give rise to soluble molecules which circulate 
in the plasma (Fey and Colten, 1981); there is additional synthesis in the 
liver (Chaplin, 1985). Recent evidence has shown that there are two 
genes, 21-OHA and 21-OHB, within the S region that code for 21-hydroxyl-
8 
ase, a cytochrome P-450 containing enzyme which has a specificity for 
steroid 21-hydroxy!ation (White et al., 1984). These genes have been 
located on the 3' side of the Sip and C4 genes (see Figure la). 
The linkage of the complement components within the MHC has been 
established in several species including man (Alper, 1981), mouse 
(Shreffler, 1976), guinea pig (Shevach et al., 1976), rhesus monkey 
(Ziegler et al., 1975) and chimpanzee (Raum et al., 1980). Thus, it seems 
likely that the location of the components is a result of selective pres­
sure, the nature of which is unknown. The class III genes are much less 
polymorphic than the classes I and II genes. At the protein level, there 
is no evidence for an evolutionary relationship between class III genes 
and classes I and II genes. On a functional level, there is no evidence 
for shared activities or concerted regulation of expression of class III 
and classes I and II genes (Chaplin, 1985). However, some variants of the 
class III genes have been shown to be associated with susceptibility to 
certain autoimmune diseases, a finding which may imply a role for the 
class III genes in the regulation of normal immune responsiveness (Porter, 
1983). 
The genes currently known to exist in the S region occupy approxi­
mately 60-70 kb of the total 250 kb of cloned DNA from this region 
(Chaplin, 1985). Sufficient material is available to encode several addi­
tional genes. Molecular linkage at the DNA level, of class III genes to 
classes I or II genes has not yet been accomplished. Further understan­
ding of the placement of the class III genes within the MHC may come with 
the discovery of additional structural or regulatory genes within the 
region. 
Class 2 antigens 
The murine class I antigens are encoded by 4 closely linked, but 
distinct regions of the MHC, K, D-L, Q and TL. As mentioned earlier. 
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there are two separate categories of class I antigens, those of the H-2K 
and D-L regions and those of the Q/TL region. The molecules of the H-2K 
and H-2D-L regions are cell surface polypeptides which are found on almost 
all cell t>pes and are highly polymorphic. They are involved in signaling 
effector T cells during cell mediated immunity (Klein et al., 1983). The 
molecules of the Q/TL region have a much more limited cell distribution, 
exhibit lower polymorphism and are not required for T cell mediated immu­
nity (Flaherty, 1980; Michealson et al., 1983). 
Class I genes The genes encoding the murine class I antigens be­
long to a large multigene family (Steinmetz et al., 1981a), that includes 
the immunoglobulin genes, the class II genes, the Thy-1 gene and the T 
cell receptor gene (Steinmetz et al., 1981a; Hood et al., 1985). The 
class I genes of two strains of mice, BALB/c (H-2'^) and C57BL/10 (BIO) (H^ 
have been extensively studied (Winoto et al., 1983; Weiss et al., 
1984). In addition, there is limited information available for the AKR 
(H-2^) mouse strain (Steinmetz et al., 1984). Analysis of genomic clones 
of the BALB/cJ strain has revealed that there are a total of 35 class I 
genes (Winoto et al., 1983). [Unpublished reports suggest that this num­
ber has been reduced to 32 (Wake et al., 1985).] The BALB/cJ class I 
genes have been assigned to 13 DMA clusters, containing between 1 and 7 
class I genes each (Steinmetz et al., 1982; Winoto et al., 1983). A major­
ity of these genes are located in the Q/TL region (see Figure lb). In BIO 
mice, a total of 26 class I genes have been described (Weiss et al., 
1984). Again, a majority of these genes lie in the Q/TL region (Figure 
lb). 
Comparison of the BIO and BALB/c gene maps (Figure lb) reveals that 
there are BALB/c genes equivalent to nearly all of the 26 BIO genes, but 
that there are several BALB/c genes that do not have counterparts in the 
BIO genome. These genes are shown in Figure Ic. The BIO H-2D^ gene bears 
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some resemblance to the H-2L^ and the H-2D^ genes of the BALB/c strain. 
The DNA sequence suggests that the H-2D^ gene and H-2l^ gene are allelic 
genes in 810 and BALB/c mice (Maloy and Coligan, 1982). There appears to 
be no BIO Class I gene which is equivalent to the BALB/c H-2D^ gene. DNA 
polymorphism is high in and around the H-2K and H-2D-L region genes. 
The Q/TL region, in particular that portion of the region that en­
codes the Qa-2 antigen, is of especial interest to this dissertation. The 
DNA in and around the Q/TL region is not as polymorphic as that around the 
H-2K, D-L regions. The genes of the Q/TL region are similar in structure 
and organization. The differences between the BIO and BALB/c strains in 
the Q/TL region are shown in Figure lb and Ic. A polymorphic DNA segment 
appears to exist between the BIO and BALB/c strains at the to 
region. In addition, the 7^ region of the BALB/c appears to be deleted in 
the BIO strain. 
The location of the gene which encodes the Qa-2 antigen is the sub­
ject of some controversy. In the BALB/c strain, it is believed that this 
gene is located in cluster 6 (Goodenow et al., 1982), as shown in Figure 
Ic. However, as pointed out by Mellor (1986), it is curious that this 
gene has no apparent counterpart in the BIO strain, as both BALB/c and BIO 
mice type as Qa-2"'". Mel lor et al. (1984) have suggested that the gene(s) 
for the Qa-2 antigen in BIO mice, lies within the ^ to ^ region, but 
most likely in 5Z. o*" both. In addition, several genes corresponding 
to the BIO to QIO*^ DNA segment seem to be absent in the AKR (H-2^) 
mouse strain (Qa-2"). Thus, it seems likely from these data that cluster 
1, encoding from the BALB/c mouse, is equivalent to the 
(^6^/Q7^ gene segment in the BIO mouse (Mellor, 1986). Recent studies by 
Mellor (1986) have shown that a deletion of genes ^ and 6^ may have taken 
place in the BALB/cBy mouse strain (Qa-2"), which is derived from the 
BALB/cJ strain (Qa-2"*'). This alteration may be associated with expression 
11 
of the Qa-2 antigen. This controversy should be resolved when the cloning 
and sequencing of the DNA from each of these strains has been completed. 
Studies of cloned class I genes have shown that the class I genes are 
made up of 8 exons which correspond to the polypeptide domains (Steinmetz 
et al., 1981b). The first exon encodes the leader sequence, exons 2-4 
encode the oj, 02» and 03 domains, respectively. The fifth exon encodes 
the transmembrane portion of the molecule, while exons 6-8 encode the 
cytoplasmic portion of the molecule and the 3' untranslated region. The 
reason for the split of the cytoplasmic portion into three exons is un­
known. Southern blot analysis of sperm and liver DNA has shown that the 
genes are not rearranged during development (Steinmetz et al., 1981b). 
The general structural features of these genes resemble other eukar-
yotic genes (Hood et al., 1983). The introns have 6T/AG nucleotide se­
quences at their boundaries. These sites may be important in RNA splic­
ing. The 5' flanking regions of the first H-2 gene isolated, 27.1, con­
tain the eukaryotic promoter sequences: CAAT and TATA at positions 81 and 
53 upstream of the AUG start codon. The gene also contains the recogni­
tion sequences for polyadenylation, AATAA. 
Complexity and polymorphism are the major distinguishing features of 
the MHC (Klein et al., 1983). Comparisons of cloned K, I and S regions of 
different mouse strains have shown that there are variable and conserved 
tracts of DNA in the MHC (Steinmetz et al., 1984). The K, A^, Ag and 
Eg genes are located in a variable tract and the nonpolymorphic MHC gene, 
E^, is located in conserved tract. The sequence variability is not con­
fined to coding sequences, but occurs in the flanking regions as well. 
Any mechanism proposed to generate the extreme pol^orphism of some MHC 
alleles must explain why variable and conserved tracts of DNA exist. 
There are several theories on the origin of the complexity and poly­
morphism of the MHC. The most popular theory, proposes that polymorphism 
12 
and complexity are a result of rapid evolution, and that the complex is 
undergoing constant contraction and expansion (Silver and Hood, 1976). 
During rapid contraction, the number of genes is reduced by unequal cros­
sing over or a similar mechanism and then expansion occurs by gene dupli­
cation. Contraction leads to gene homogeneity, while expansion, in con­
junction with gene conversion, leads to diversification and polymorphism. 
This hypothesis is supported by studies of several H-2K region alleles, 
including mutant alleles (bm), at the molecular level (Pease et al., 1983; 
Schulze et al., 1983). These studies show that there is potential for 
block transfer of genetic information among the genes of the MHC. In 
addition, Mellor et al. (1984) have shown that the 010^ gene could have 
acted as a donor gene during gene conversion events leading to the gene­
ration of the H-2K^'"^ allele of the BIO strain. Weiss et al. (1984) have 
shown that the to genes of the £ region of the BIO strain are very 
similar to the gene pair at the H-2K region. They suggest that multiple 
duplications of an ancestoral pair of class I genes in the £ region has 
occurred and that the H-2K region was generated by duplication or trans­
location of a similar pair of ancestoral genes at the £ region to the 
present location of the H-2K region. Thus, large numbers of class I genes 
at.the Q/TL regions may act as stockpiles of information which, through 
gene conversion mechanisms, are responsible for the generation of high 
diversity in the H-2 complex. 
Sequence and domain similarities indicate that class I and class II 
genes descend from a common ancestor with an Ig-like domain. Arguments 
have been advanced in favor of $2 microglobulin (Cunningham and Berggard, 
1974) and a class II g-like gene (Kaufman et al., 1984) as the ancestor 
of the MHC molecules. Others believe that there was a common ancestoral 
gene that gave rise to all members of the multi-gene family. 
13 
Class 2 proteins The class I molecules of the H-2 complex are the 
most thoroughly characterized molecules of the MHC antigens. The class I 
antigens are made up of two chains, a 45,000 dalton class I polypeptide 
encoded in chromosome 17 and $£ microglobulin, a 12,000 dalton polypeptide 
encoded in a gene located on chromosome 2. The 45,00 dalton protein is a 
transmembrane protein. The association with the nonmembrane bound $2 
microglobulin is noncovalent. Association of the class I polypeptide with 
the $2 microglobulin is necessary for incorporation in the plasma membrane 
(Michealson, 1983), although this has recently been questioned (Bushkin et 
al., 1986). The heavy chain of the antigen is approximately 350 amino 
acids and can be divided into 5 domains (Nathenson et al., 1981). The 
extracellular portion of the antigen consists of three domains, aj, «2 
03, each of approximately 90 amino acids. The oj domain contains the NH2 
terminal and a glycosylation site. The 02 and 03 domains contain disul­
fide bonds which span about 60 residues. Analysis of peptide fragments, 
generated by proteolytic digestion, have shown that the B2 microglobulin 
is associated with the 03 domain (Yokoyama and Nathenson, 1983). The 
transmembrane portion of the antigen has a hydrophobic and uncharged core 
of about 25 amino acids that spans the lipid bilayer. The cytoplasmic 
portion of the molecule contains about 34 amino acids which are 50% hydro­
phobic in nature and may be involved in the interaction with submembranous 
structures. Sequence comparisons among antigens show that there is an 
overall similarity among the antigens but there are numerous amino acid 
differences which result in 15 to 20% sequence divergence. 
As mentioned earlier, the class I molecules can be separated into two 
categories, those encoded in the J( and D-L subregions (transplantation 
antigens) and those encoded in the Q/TL region. Of the Q/TL molecules, 
those of the Qa-2 family of antigens are the best characterized. The Qa-2 
family is the collection of antigens coordinately expressed with the Qa-2 
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molecule (Flaherty et al., 1985). The family is made up of Qa-2, -3, -5, 
-6, -7, -8, and -9 antigens. All of these antigens, with the exception of 
Qa-6, are encoded in the ^ region. The Qa-6 antigen is encoded in the TL 
region. The characteristics of the Qa-2 antigens as compared to the H-
2K/D-L antigens are shown in Table 1. Only one of the Qa-2 family has 
been biochemically characterized, Qa-2. Although Qa-2 is slightly smaller 
than the H-2K/D-L molecules, it is as similar to H-2K/D-L as K and D are 
to each other (Soloski et al., 1982). It is possible that all the Qa-2 
family of antigens, with the exception of Qa-6, are antigenic specifici­
ties on one molecule. The class I antigens of the Q/TL region are expres­
sed in a tissue specific manner. As stated before, these antigens are 
much less polymorphic then transplantation antigens (Flaherty, 1980). 
Whereas there are over 200 alleles in both the H-2D-L and K genes, 
only 2 alleles exist for the Qa-2 gene. One of the Qa-2 alleles codes for 
the presence of the Qa-2 antigen (Qa-2^), while the other is a null allele 
(Oa-2b). 
Mutations of the Qa-2 family lead to a loss of the antigen, not to 
the expression of any aberrant protein (Flaherty et al., 1985). The only 
other diversity seen in the Qa-2 family is quantitative. Michealson et 
al. (1981) have shown that genes within the MHC affect the level of Qa-2 
expression. Qa-2 expressing strains of mice may be divided into high and 
low expressing strains; the haplotypes rank according to their levels 
of Qa-2 expression as follows: b>d>q (Michealson et al., 1981). This 
quantitative regulation concomitantly affects other Qa-2 family members 
(Hammerling et al., 1979). Michealson et al. (1981) have shown that genes 
within the MHC affect the level of Qa-2 expression. The nature of these 
genes is not known, but they appear to be located at the D end of the H-2 
complex (Lew et al., 1986). The coordinate control of the Qa-2 antigens 
suggests that they are governed by the same regulatory process (Flaherty 
15 
Table 1. Comparison of Qa-2 to H-2K/D-L® 
Characteristic H-2K/D Qa-2 
Number of alleles 
Type of allele 
Mutations 
Quanti tati ve vari ati on 
Molecular weight 
Level of expression^ 
>200 
Structural 
Structural/deleti on 
Yes 
45 kdal. + 
100% 
Presence to absence 
Presence to absence 
Yes 
40 kdal. + g2m 
5% 
^From Flaherty et al. (1985). 
^As compared to H-2K/D-L expression on lymphoid cells (Soloski et 
al., 1982). 
et al., 1985). 
A third category of class I antigens has recently been characterized 
(Lew et al., 1986). These molecules, designated QIO and encoded in the ^ 
region, have been shown to be secreted rather then membrane bound (Maloy 
et al., 1984). Structurally, the QIO molecules are similar to membrane 
bound class I molecules; they exhibit greater than 80% sequence homology 
to the membrane bound antigens (Kress et al., 1983) and bind $2 microglob­
ulin. The QIO molecules exhibit several characteristics that distinguish 
them from other class I molecules. They are truncated, the entire cyto­
plasmic region is missing (Cosman et al., 1982a), contain several amino 
acids not common in other class I molecules (Kress et al., 1983) and lack 
a glycosyl unit in the «2 domain (Cosman et al., 1982b). In contrast to 
the H-2K/D-L molecules, QIO mRNA is detectable in the liver only (Cosman 
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et al., 1982b). QIO is expressed in all inbred mouse strains tested, 
regardless of H-2 haplotype (Malay et al., 1984); the molecule does not 
have allodeterminants (Kress et al., 1983). Serum levels of QIO vary with 
haplotype; the z and s haplotypes have greater levels of QIO than the f 
haplotype (Lew et al., 1986). The quantitative regulation QIO maps to the 
right of the H-2S region and may be under the same regulatory mechanism as 
the Qa-2 family. Recent evidence has shown that the H-2K^ and QIO mole­
cules originate from the same mRNA species by alternate splicing (Lalanne 
et al., 1985). 
Class I function The ability of organisms to discriminate self 
from nonself is one of the fundamental processes in common to eukaryotes. 
In mammals, and perhaps in lower eukaryotes as well, self-nonself 
discrimination is controlled by the MHC. Class I antigens play a major 
role in the immune processes of self/nonself recognition. 
The class I antigens of the H-2K/D-L regions are the transplantation 
antigens and act as restriction elements for cytotoxic T cells. These 
antigens play a dual role in the generation of the immune response acting 
as alloantigens in transplantation and as self markers in cell mediated 
immunity to antigenically modified syngeneic tissues. The restriction of 
cytotoxic T lymphocyte activity by H-2K, D-L molecules was first noted by 
Zinkemagel and Doherty in 1974. 
The function of the class I antigens of the Q/TL region remains an 
enigma. No role of the Qa-2 antigen as a restriction element has been 
found (Forman et al., 1982). This finding is surprising considering the 
high degree of structural homology between Qa-2 and H-2 molecules. This 
homology suggests that Qa-2 molecules play some role in an immune-related 
function or in cellular communication. Their limited tissue distribution 
and differential expression during differentiation suggests that these 
molecules may play a role in development. It is hoped that the analysis 
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of the genes for the Q region antigens will lead to a greater understand­
ing of their expression and function in mice. 
The MHC antigens have been shown to play a role in a number of non­
immune processes (Edidin, 1983). These include development, reproduction, 
aging and cell metabolism. Curtis and Rooney (1979) have shown that con­
tact inhibition of fibroblasts and cell/cell adhesion have a requirement 
for H-2K/D matching. MHC antigens have also been shown to be involved in 
hormone and epidermal growth factor binding to their receptors (Lafuse and 
Edidin, 1980; Schreiber et al., 1984; and Fehlman et al., 1985). The role 
of the MHC in aging is discussed in Popp and Popp (1981). Several studies 
have linked the MHC to reproduction. In chickens, higher egg production 
is associated with the chicken MHC (Simonsen et al., 1982); in pigs, ovu­
lation rate is associated with the pig MHC (Rothschild et al., 1984); in 
rats, a "growth and reproduction complex" which influences body size and 
fertility is linked to the rat MHC (Kunz et al., 1980); in mice, mating 
preference (Yamaski et al., 1976), fetal loss and fetal weight (Melnick et 
al., 1981); and vaginal septa frequency (Bonner and Tyan, 1983) are asso­
ciated with the H-2 complex; and in humans, recurrent spontaneous abortion 
has been shown by some groups (Scott, 1982; Singh and Ganbel, 1982; and 
Bolis et al., 1985), although not by others (Caudle et al., 1983; Persitz 
et al., 1985) to be associated with the HLA complex. There have also been 
suggestions that H-2 antigens may be important in development (Solter and 
Knowles, 1979; Moruela and Edidin, 1980). The MHC was first shown to be 
involved in the timing of early mouse development by Verbanac and Warner 
(1981). This finding is pivotal for this thesis and will be discussed in 
detail later. 
Two extremes have been suggested for the primordial function of MHC-
like molecules. One suggests that these molecules function in allorecog-
nition (Burnet, 1971). In this view polymorphism, not multigenicity, is 
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important. The second view suggests that early MHC molecules were in­
volved in syngeneic recognition and cooperation, perhaps during tissue or­
ganization during development (Artz and Bennet, 1975). The varied func­
tions of the evolved class I molecules support both of these extremes. 
Polymorphism is crucial for the role the MHC antigens play in the iitmiune 
response. The radical functions of the antigens in other processes, in- ' 
eluding development, support the theory that the function of the antigens 
in immune processes are elaborations of an earlier function in develop­
ment. 
Early Mouse Development 
Early mammalian development involves the formation of a set of extra­
embryonic structures that enclose the embryo and allow for exchange of 
metabolites with the mother. Prior to implantation the murine preimplan-
tation embryo is a free floating entity, independent of the mother, nur­
tured by uterine secretions (murine embryo development is reviewed in 
Johnson and Everritt, 1980). During this time the embryo, located in the 
oviduct and then the uterus, undergoes between five and six cleavage divi­
sions. Six definable stages occur during cleavage: fertilized ovum 
(oocyte), 2 cell, 4 cell, 8 cell, morula and blastocyst. In the mouse, 
the preimplantation period lasts approximately 4.5 days. 
The murine ovum has a diameter of 95 pm and is surrounded by the zona 
pellucida. The zona pellucida is an acellular structure secreted by the 
follicle cell and composed of glycoproteins. It forms a porous envelope 
around the embryo (Bleil and Wassarman, 1980). Following fertilization, 
the zona pellucida undergoes structural rearrangement that prevents fur­
ther sperm penetration (Bleil et al., 1981). Recent studies have shown 
that the zona pellucida may also act to prevent cytotoxic T cells from 
killing preimplantation embryos (Ewoldsen et al., 1986). 
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Early cell division is asynchronous, often leading to embryos with 
odd numbers of cells. The overall size of the embryo remains the same 
from the oocyte to blastocyst stage, but as cleavage occurs the large 
amount of cytoplasm present in the oocyte is gradually reduced to a more 
normal nucleus to cytoplasm ratio. During cleavage division from the 8 
to 16 cell (morula) stage, the embryo undergoes two important changes. 
First, the embryo changes its morphology by undergoing compactation. 
Second, the embryo increases its biosynthetic processes. There is a 
marked increase in RNA synthesis and protein synthesis. It is during the 
transition from the morula to the blastocyst stage that the embryo leaves 
the oviduct and enters the uterus. 
The formation of the morula stage embryo represents the first stage 
of differentiation. Prior to this stage all of the blastomeres are equi­
valent (McLaren, 1976). The morula has "inside" cells and "outside" 
cells, which form the different parts of the blastocyst. The blastocyst 
is made up of two cell types, an outer layer of trophectoderm cells which 
surround the blastocoelic cavity containing blastocoelic fluid, and a 
cluster of cells, located at one end of the cavity, the inner cell mass 
(ICM). The trophectoderm gives rise to the placenta and extraembryonic 
membranes; the ICM forms the embryo proper. The location of the blasto­
meres during cleavage seems to determine their fate in differentiation 
(Tarkowski and Wrobleska, 1967). Blastomeres that remain on the outside 
of the embryo during cleavage form the trophectoderm and the inner cells 
form the ICM. This hypothesis is supported by studies showing that when 
^H-thymidine labelled cells are stuck to the outside of unlabeled 4 to 16 
cell embryos, most of the label is located in the trophectoderm (Hillman 
et al., 1972). 
Implantation occurs four to five days following fertilization and is 
preceded by hatching of the blastocyst from the zona pellucida. Implan-
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tatlon in the mouse is invasive. Initially, the trophectoderm cells make 
contact with the uterine epithelium. The immediate maternal response is 
an increased vascular permeability in stromal tissues caused by a progres­
sive sprouting and ingrowth of capillaries. This process is known as 
decidualization and is especially prevalent in humans and rodents. The 
embryo then invades the uterine endometrium, and implantation is complete. 
The discovery of a means to culture early embryos in vitro in 
chemically defined medium (Whitten and Biggers, 1968) has enabled investi­
gators to study the biochemistry and molecular biology of early embryos. 
The large amount of cytoplasm present in the oocyte contains essential 
material for cleavage to the two cell stage. At the two cell stage, the 
embryo's own genes start to contribute to embryonic activity and develop­
ment. Warner and Hearn (1977) showed that RNA polymerase activity is 
detectable in 2 cell stage preimplantation embryos. Sawicki et al. (1981) 
have found evidence of paternal genome expression in 2 cell stage embryos. 
Wudl and Chapman (1976) were able to detect the paternal form of g-
glucuronidase as early as 57 hours post fertilization. Thus, the mam­
malian genome is transcribed very early in development. 
Molecular events in early development may be followed by monitering 
enzyme activity in the preimplantation mouse embryo. Brinster (1965) was 
the first researcher able to detect an enzyme, lactate dehydrogenase, in 
the oocyte as well as during all early embryonic stages. He was also able 
to detect measurable levels of glucose-6-phosphate dehydrogenase 
(Brinster, 1966) and hexokinase activity (Brinster, 1968) in early em­
bryos. In order to show that the enzyme activities were not a result of 
unmasking maternal mRNA, Brinster (1973) showed that the paternal variant 
of glucose phosphate isomerase could be detected at the 8 cell stage of 
development. 
In addition to the internal change that occurs during the preimplan-
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tation stages of development, a great deal of interest has been focused on 
the changes that occur on the cell surface of the embryo and how these 
relate to development. One way to study these changes is to examine the 
nature of the molecules expressed on the embryo surface. Immunological 
techniques have been used for this purpose and the results were reviewed 
by Johnson and Calarco in 1980. These studies have suggested six possible 
functions for molecules expressed on the embryo surface: (1) recognition 
(sperm-egg, ICM-trophectodenn, trophectoderm-uterine cells); (2) adhesion 
(nonspecific and cell type specific); (3) communication; (4) motility 
(invasiviness by trophectoderm cells); (5) protection of the fetus from 
maternal immunological attack; and (6) receptors for the induction of 
intercellular changes. The specialized case of the expression of H-2 
antigens on early embryos and the possible role they may play in develop­
ment is discussed in a later section. 
The Fed Gene 
The timing of mammalian development is crucial for successful implan­
tation. In order for implantation to occur, both the embryo and uterus 
must be at the correct developmental stage. In mice and rats, if the 
embryo is ahead of the uterus in maturity, it can remain at the blastocyst 
stage until the uterus matures further. The converse is not true, if the 
embryo develops too slowly, it misses the short period of uterine recep­
tivity during which implantation is possible. Thus, the timing of preim-
plantation embryo development is important in embryonic mortality. 
There is very little known about the genetics which regulate the 
timing of early development. Whitten and Dagg showed in 1972 that at the 
blastocyst and 8 cell stage there are, on the average, fewer cells in the 
embryos of BALB/c mice compared to strain 129 mice. The difference was 
interpreted to be due to a difference in cleavage rate. McLaren and 
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Bowman showed in 1973 that throughout the preimplantation period C3H mice 
have fewer cells per embryo than mice of the outbred Q strain, or the 
inbred strains C57BL, RIII and JU. Titenko demonstrated in 1977 that 
inbred CBA mice have fewer cells at a given time than either BALB/c or 
C57BL mice. More recently, Niwa et al. (1980) and Shire and Whitten 
(1980) suggested that there was a genetic factor controlling the timing of 
embryonic cleavage divisions. 
The fact that the slow developing strains in the Titenko (1977) and 
McLaren and Bowman (1973) studies, C3H and CBA, were of the H-2*^ haplotype 
led Verbanac and Warner (1981) to propose that the genetic factor control­
ling the rate of early development was located within the H-2 complex. 
When the number of cells per embryo at a given stage of development (blas­
tocyst stage) of a series of inbred mouse strains of different H-2 haplo-
types was examined, it was found that embryos from strains of the H-2*^ 
haplotype develop slower then those of the other haplotypes tested ( a, b, 
d, q and s). In order to determine if the difference in development rate 
was due to genes in the H-2 complex or other genetic factors, two sets of 
congenic strains were examined (Goldbard et al. 1982a). In each case, a . 
change in the genetic composition at only the H-2 complex (from H-2*^ to H^ 
^ or from H-2*^ to H-2*^) changed the rate of development. These results 
led the investigators to propose the existence of an H-2 associated gene. 
Fed: Preimplantation embryo development, which influences the rate of 
early cleavage divisions. The influence of the H-2 complex on early mouse 
development was confirmed by a study examining the numbers of cells per 
embryo of a series of congenic mouse strains on the C57BL/10 background. 
Two different times of development (8 cell stage and blastocyst stage) 
were examined. The study showed that embryos of the H-2k and H-2'^ strains 
are slow developers and those of the b, d, q, s, and u haplotypes are fast 
developers. The characteristics of the Ped gene, which were known before 
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the work described in this dissertation was undertaken* are summarized in 
Table 2 and reviewed below. 
By measuring the time of ovulation, Goldbard et al. (1982a) showed 
that Fed gene expression was not evident at this time, as slow and fast 
developing strains ovulated within two hours of each other. The time of 
the first cleavage division of slow and fast developing strains was also 
examined, and it was found that slow developing strains undergo the first 
cleavage 3-6 hours later than fast developing strains. This study also 
showed that rate of development of the congenic strain (BIO.BR} fell be­
tween the slow (C57BR/cdj) and fast (C57BL/10) developing strains; there­
fore, there must be background genes which influence development, in addi­
tion to the H-2 associated Fed gene. 
In this same study, the rate of embryonic development was examined by 
measuring the numbers of cells per embryo at different times during preim-
plantation development. The results showed that the Fed gene influences 
the rate of development. This finding is in contrast to the McLaren and 
Bowman (1973) study which suggested that it is the time at which cleavage 
began, and not the rate of cleavage that caused the differences in cell 
number between strains. It is possible that the discrepancy is a result 
of the two laboratories using different strains of mice and studying em­
bryos at different times in development. 
The genetics of the Fed gene were studied by examining the C57BL/10Sn 
(H-2*^9 Ped^®^^), BIO.BR (H-2*^, Ped^^®") and crosses between the two 
strains (Goldbard et al., 1982b). In addition, Fg and backcross genera­
tions were studied. The results of the Fj crosses showed that the fast 
Fed allele is dominant and that there is no effect of the maternal egg 
cytoplasma on Fed gene expression. The analysis of Fg and backcross gen­
erations showed that the Fed gene is modified by environment and genetic 
background. 
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Table 2. Known characteristics of the Fed gene (1982) 
1. There is a gene Fed (preimplantation embryo development), associated 
with the complex, that influences the rate of preimplantation 
embryonic development. 
2. There are two functional alleles of the Fed gene which have been 
designated fast and slow. The fast allele is associated with the 
^ b, d, q, s and u haplotypes, while slow development is associated 
with the k and r haplotypes. 
3. The Fed gene does not influence the time of ovulation. 
4. Fed gene expression is apparent at the time of the first cleavage 
division. 
5. The fast allele of the Fed gene is dominant, with no obvious 
maternal effects. 
By determining the number of cells per embryo of the BIO.A strain 
2^), Goldbard and Warner (1982) were able to localize the Fed gene to the 
D end of the H-2 complex. The H-2^ haplotype is a recombinant haplotype, 
of the H-2^ and H-2^ haplotypes; there is a crossover point distal to the 
I-E region so that the a haplotype carries the k allele in the K and 2 
regions and the d allele in the S and jD regions. BIO.A embryos are fast 
developers; therefore, the fast Fed allele is located in the ^ or £ region 
of the H-2 complex. The £ region has been found to control the expression 
of other genes within the H-2 complex (Lew et al., 1986). At the time of 
these studies, the location of class I genes in the Q/TL regions, distal 
to the £ region was unknown. The importance of this point will be appar­
ent later in this dissertation. 
The nature of the Fed gene product is unknown. Goldbard et al. 
(1982b) have proposed that the Fed gene product is the class I H-2 anti-
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gens themselves and that the control of the rate of cell division is one 
of the pleiotrophic effects of these antigens. If the class I molecules 
play a role in the control of the rate of development, and are the Ped 
gene products, they must be present at the time of the first cleavage 
division, as this is when the effect of the Ped gene is first observed. 
The search for H-2 antigens on the surface of preimplantation embryos is 
discussed in the next section. 
H-2 Antigen Expression on Early Embryos 
Studies of H-2 antigen expression on early embryos have been limited 
and controversial. Results from a number of laboratories are summarized 
in Table 3. While H-2 antigens have been detected on unfertilized mouse 
ova (Heyner, 1973) and spermatozoa (Johnson and Edidin, 1972), results of 
H-2 expression on embryos are mixed, with a majority of the early reports 
being negative (see Table 3). However, the negative reports may be due to 
the relatively insensitive assays used (see Table 3). These studies are 
contradicted by studies involving transplantation experiments. Transplan­
tation of blastocysts to allogeneic hosts, after treatment of the blasto­
cysts with an anti-H-2 serum or preimmunization of the recipients have 
shown that the transplanted embryos fail to develop (Kirby et al., 1966; 
Kirby, 1968; and James, 1969). These results suggest that the blastocyst 
stage embryos must express MHC antigens. 
Through the use of a sensitive electron microscopic immunoperoxidase 
technique and specific anti-H-2 antisera, Searle et al. (1976) were able 
to detect H-2 antigens on the trophectoderm of blastocyst stage embryos. 
No H-2 antigens were detectable on earlier stages using this method. 
Warner and Spannaus (1984) were also able to detect H-2 antigens on the 
trophectoderm of blastocysts using this technique and congen'ic alloanti-
sera. In addition to the congenic alloantisera, Warner and Spannaus 
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Table 3. Detection of H-2 antigens on prelmplantatlon mouse embryos 
Study Antisera Assay 
Embryonic 
Stage Result 
Jones, 1969 
Palm et al., 
1971 
Heyner, 1973 
congenic 
alloantisera 
congenic 
alloantisera 
congenic 
alloantisera 
Muggleton-Harris congenic 
and Johnson, 1976 alloantisera 
Searle et al., 
1976 
Krco and 
Goldberg, 1977 
Sellens, 1977 
Webb et al., 
1977 
Heyner and 
Hunziker, 1979 
Cozad and 
Warner, 1981 
Sawicki et al., 
1981 
Cozad and 
Warner, 1982 
congenic 
alloantisera 
congenic 
alloantisera 
congenic 
alloantisera 
congeni c 
alloantisera 
congenic 
alloantisera 
congenic 
alloantisera 
congenic 
alloantisera 
congenic 
alloantisera 
transplantati on blastocyst 
immunofluorescence 2 cell 
immunofluorescence blastocyst 
immunof1uorescence 
i mmunoperoxi da se 
labeling 
cytotoxicity 
mixed 
heamadsorption 
125-1 labeling 
+ immunoppt. 
2 cell 
morula 
blastocyst 
8 cell 
blastocyst 
8 cell 
blastocyst 
outgrowth 
eggs 
4 cell 
morula 
blastocyst 
oocytes 
2 cell 
immunof1uorescence 
cytotoxicity blastocyst 
immunoppt. 
cytotoxicity 
2 cell 
8 cell 
+ 
+ 
+ 
+ 
27 
Table 3. cont. 
Study Antisera Assay 
Embryoni c 
Stage Result 
Warner and congenic i mmunoperoxi dase 2 cell 
Spannaus, 1984 alloantisera labeling 8 cell + 
blastocyst + 
monoclonal 
antibody blastocyst + 
Goldbard et al.. monoclonal ELISA blastocyst + 
1984® antibody 
Warner et al. congenic cytotoxicity 
1985b alloantisera and 
nonabsorbed immunoperoxi dase blastocyst + 
absorbed labeling blastocyst +/-
Goldbard et al.. monoclonal ELISA oocyte + 
1985® antibody 2 cell + 
8 cell + 
blastocyst + 
®Work described in this thesis. 
(1984) used a monoclonal antibody, 11-4.1 (anti-H-2'^) to search for H-2 
antigens on preimplantation mouse embryos. Specific labeling of BIO.BR 
(H-2*^) blastocysts but not of C57BL/10 (H-2^) blastocysts was seen. 
Webb et al. (1977) were able to detect H-2 antigens on the inner cell 
mass of late blastocyst stage embryos using ^^®I-lactoperoxidase labeling 
and immunoprecipitation methods. The investigators were unable to detect 
H-2 antigens on the trophectoderm or on any earlier cleavage stages using 
this technique. Sawicki et al. (1981) performed immunoprecipitation and 
two dimensional gel electrophoresis to detect B2"'"''croglobulin in preim-
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plantation mouse embryos, gg microglobulin Is normally associated with 
class I antigens and its expression in early embryos suggested that they 
express class I molecules. 
Krco and Goldberg (1977) were able to detect H-2 antigens on 8 cell 
stage embryos using MHC-directed alloantisera in a complement-dependent 
cytotoxicity assay. The detection of H-2 antigens on 8 cell stage embryos 
was confirmed by Cozad and Warner (1982). Cozad et al. (1981) used a 
cytotoxicity assay based on the incorporation of ^H-thymidine into DNA by 
live embryos but not by embryos killed by treatment with anti-H-2 antisera 
plus complement. Using this assay, Cozad and Warner had previously de­
tected H-2 antigens on blastocyst embryos of the H-2 a, b, d and k haplo-
types. 
One of the criticisms of the serological detection of H-2 antigens is 
the questionable specificity of the antisera. With the exception of the 
Warner and Spannaus and Goldbard et al. (1984; 1985) studies, all of the 
above studies employed conventional antisera. The use of highly specific, 
well-characterized monoclonal antibodies should eliminate many of the 
specificity criticisms. 
Antibody specificity can be confirmed by absorption studies. When 
Warner et al. (1985b) compared the cytotoxic effects of absorbed and non-
absorbed antisera on blastocyst stage embryos, the absorbed antisera 
showed a 50% reduction in cytotoxicity when compared to nonabsorbed sera. 
This indicates that in addition to expressing H-2 antigens, the embryos 
also express other antigens, which are detectable by the antisera. Warner 
et al. (1985b) suggest that a part of the residual cytotoxicity may be due 
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to the detection of viral antigens expressed by the embryos. 
The molecular structure of H-2 antigens detected on early embryos is 
unknown. There are several hints in the literature that embryonic H-2 
antigens may be different than adult H-2 antigens. Cozad and Warner 
(1981) have observed some aberrant crossreactions with antisera used on 
2^ and H-2^ blastocysts. Ostrand-Rosenberg et al. (1977) found similar 
crossreactions when studying blastocyst outgrowths of the H-2^ and H-2^ 
haplotypes. Cozad and Warner (1981) suggested that these crossreactions 
were the result of embryonic expression of general multispecific H-2 anti­
gens, which later give rise to the haplotype specific H-2 antigens found 
in adult tissue. This type of molecule would enable the embryo, expres­
sing paternal antigens, to escape the maternal immune system. The hypo­
thesis suggests that H-2 antigens found on early embryos are not func­
tional, that is they are not able to be recognized by cells of the Immune 
system, e.g., cytotoxic T lymphocytes (CTL). However, Ewoldsen et al. 
(1986) have recently shown that CTLs are able to recognize and kill em­
bryos, once the zona pellucida has been removed. Implying that the em­
bryonic H-2 antigens are functional. 
The development of cDNA probes specific for H-2 mRNA has allowed 
investigators to examine the transcription of genes by embryos. Using 
a cDNA probe specific for class I antigens, Warner et al. (1985a) were 
able to detect mRNA for class I antigens in early embryos. In contrast, 
Ozato et al. (1985) were unable to detect mRNA for class I antigens until 
the ninth day of gestation. However, the earliest stage examined in the 
Ozato et al. study was the eighth day of gestation. It is possible that 
30 
class I antigen expression is reduced during the time of implantation, and 
expression is not evident again until the later stages of development. H-
2 antigen modulation has been proposed as a means by which tumor cells 
escape immunosurveillance (Goodenow et al., 1985} and may also play a role 
in development. 
In summary, recent evidence indicates that early embryos do express 
H-2 antigens. Interestingly, la antigens have never been detected on 
early embryos (Delovitch et al., 1978; Jenkinson and Searle, 1979; and 
Heyner and Hunziker, 1979). The nature of embryonic H-2 and la antigens 
during development remains to be elucidated. One of the major goals of 
this work was the development of a sensitive assay that would permit the 
study of the early embryonic cell surface with monoclonal antibodies to H-
2 (class I) and la (class II) HHC antigens. 
Specific Goals 
The major purpose of this work was to further characterize the H-2 
complex associated Fed gene, which controls the rate of early mouse embryo 
development; The characterization involved the development of a highly 
sensitive assay to permit detection of mouse MHC antigens on the embryonic 
cell surface. The assay was used to study MHC antigen expression and 
synthesis during development. One of the MHC class I antigens was puri­
fied and used in a blocking study to confirm the presence of H-2 antigens 
on embryos. 
A second, more classical, approach was also undertaken to characte­
rize the Fed gene. First, the location of the gene was determined through 
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the use of congenic mouse strains. Second, segregation analysis was done 
to determine if the Fed gene was linked to the H-2 complex. 
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MATERIALS AND METHODS 
Embryos 
Embryos for these studies were collected from the following mouse 
strains: CFl (Charles River Breeding Laboratories, Wilmington, MD); 
C57BL/6J, C57BL/10Sn, C57BL/10J, BIO.BR/J (Jackson Laboratories, Bar 
Harbor, MA); BIO.AM, B10.A(4R), B10.A(5R) (Chella David, Mayo Clinic, 
Rochester, MN); B6.K1 and B6.K2 (Lorraine Flaherty, New York State Depart­
ment of Health, Albany, NY). (BIO.BR x C57BL/10Sn)Fi and (B6.K1 x 
B6.K2)Fi mice were produced in our laboratory. Mice were housed in a 
light-controlled room (14 hour light cycle, 10 hour dark cycle). Mature 
female mice were superovulated with 5 I.U. pregnant mare serum (PMS, 
Sigma, St. Louis, MO) at the ninth hour of the light cycle, followed 48 
hours later by 5 I.U. human chorionic gonadotrophin (hCG, ICN Nutritional 
Biochemicals, Cleveland, OH). Immediately after hCG injection, a female 
was placed with a male and checked the following morning for the presence 
of a vaginal plug. Embryos were collected, into either Whitten and 
Biggers' medium (Whitten and Biggers, 1968) or Brinster's medium (GIBCO, 
Grand Island, NY), 93, 89, 65, 41, or 17 hours post-hCG injection. These 
collection times correspond approximately to the blastocyst or morula (93, 
89), 8 cell (65), 2 cell (41), and 1 cell (17) stages of development. For 
some experiments, oocytes were collected 17 hours post-hCG. In these ex­
periments, cumulus cells were removed with hyaluronidase before the 
experiment was undertaken (Goldbard, 1982). 
Cell Lines 
Tissue culture cell lines known to express H-2 antigens were used as 
positive controls in embryo experiments and in H-2 antigen purification 
experiments. The cells used were P815 (H-2^) mastocytoma cells, EL-4 (H^ 
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Qa-2^) T cell l^phoma cells, and RDM-4 (H-2k) cells. P815 and EL-4 
cells were obtained from the American Type Culture Collection (ATCC, 
Rockville, MD); the RDM-4 cell line was obtained from Dr. Matthew F. 
Mescher (Harvard Medical School, Boston, MA). P815 cells were maintained 
in Dulbecco's Modified Eagles Medium, with 4500 mg/ml glucose (DMEM, 
GIBCO), 10% fetal calf serum (PCS, HyClone, Logan, Utah), 0.1% antibi­
otics/an timycotics (GIBCO) and 0.5% gentamycin (Schering, Kenilworth, NJ), 
hereafter referred to as tissue culture medium A. Cells were grown at 
370c, in 5% CO2 in air. RDM-4 cells were maintained in RPMI 1640 (GIBCO), 
10% PCS, 0.1% antibiotics/antimycotics and 0.5% gentamycin. 
Antisera 
Monoclonal antibodies 
Ml/42.3.9.8, 53-7.313 (hereafter referred to as Ml/42 and 53-7), N-
S.2.1, N-S.8.1 and B8-24-3 cell lines were obtained from the ATCC and were 
maintained in tissue culture medium A at 37^0 and 5% CO2 in air. The cell 
line 11-4.1 was obtained from the Salk Institute (San Diego, CA) and main­
tained in tissue culture medium A at 37^0 and 5% CO2 in air. The YP-3 
cell line was obtained from C. Janeway, Yale Univ., New Haven, CT, and is 
described in Janeway et al. (1984). This cell line was also maintained in 
tissue culture medium A. D3.262 and 18/20 were obtained from Lorraine 
Flaherty, New York State Dept. of Health, Albany, New York, as ascites 
fluid. A summary of the properties of the monoclonal antibodies used in 
this work is given in Table 4a. 
Ml/42 and 53-7 were purified from culture supernatant by a 45% ammo­
nium sulfate precipitation, followed by Sephadex 6-200 chromatography 
(Pharmacia, Piscataway, NJ; Stallcup et al., 1981). Column fractions were 
assayed for protein content and antibody reactivity by the cell ELISA I 
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Table 4a. Monoclonal antibodies 
Antibody Species I so type Specificity Reference 
Ml/42.3.9.8 Rat IgG all H-2 Stallcup et al., 1981 
11-4.1 Mouse IgG H-2Kk 01 et al., 1978 
B8-24-3 Mouse IgG H-2Kb Kohler et al., 1981 
YP-3 Mouse IgG lA (except lAd) Janeway et al., 1984 
D3.262 Mouse IgM Qa-2 Michealson et al., 
1981 
18/20 Mouse IgG TL Michealson et al., 
1981 
53-7.313 Rat IgG Ly 1.2 Ledbetter and 
Herzenberg, 1979 
N-S.2.1 Mouse IgM SRBCa Raschke, 1980 
N-S.8.1 Mouse IgG SRBCa Raschke, 1980 
&SRBC is an abbreviation for sheep red blood cells. 
Table 4b. Summary of the second antibodies® 
Designation Specificity Source Conc. of Stock Soin. 
Rabbit anti-
mouse IgG 
Heavy and 
light chain 
Cappel 
Labs 
img/ral 
Rabbit anti-
mouse IgM 
H chain Cappel 
Labs 
Img/ml 
Rabbit anti-
rat IgG 
Heavy and 
light chain 
Zymed Img/ml 
"All Second antibodies are affinity purified. 
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(described below}. Peak fractions were pooled, concentrated to 1-2 mg/ml 
of protein and stored at -800C in 100 nl aliquots. 11-4.1, N-S.2.1, N-
S.8.1, B8-24-3 and 03.262 were purified from ascitic fluid by a two times 
sodium sulfate precipitation (final concentration 18%), achieved by adding 
an appropriate volume of a 25% saturated Na2S04 solution, followed each 
time by dialysis against phosphate buffered saline (O.OIM sodium phos­
phate, pH 7.0, PBS). Antibody concentration was calculated by measuring 
the absorbance at 280 nm, assuming an extinction coefficient of 14 (Ey et 
al., 1978). 
Conventional antisera 
Rabbit anti-mouse serum was prepared by injection of 1 x 10^ 
C57BL/10Sn spleen cells into the marginal ear vein of an 8 pound female 
New Zealand rabbit. Three injections were given (on days 1, 10, and 20) 
with a test bleeding performed on day 30. Three more booster injections 
of 1 X 10^ spleen cells were given about 6 weeks apart with a cardiac 
puncture performed after the final booster injection. The serum was col­
lected and heat inactivated at se^C for 30 minutes. 
Alloantisera were prepared by intraperitoneal injection of approxi­
mately 10^ spleen cells once a week for 7 weeks. A test bleeding was made 
and each antiserum was tested against the lymphocytes from the immunizing 
strain and also against the lymphocytes from other strains. Three more 
injections were given 1 week after the test bleeding. A second test bleed 
was done a week after the tenth injection. The mice were boosted once a 
month, then bled one week later. Cytotoxicity titers were determined by 
the cytotoxicity assay, described later. 
Polyclonal B6.K1 anti-C57BL/6 antiserum, which is specific for Qa-2 
and Qa-3 antigens, was obtained from Lorraine Flaherty and has been de­
scribed previously (Flaherty, 1982 and Flaherty et al., 1978). Affinity 
36 
purified rabbit anti-mouse IgM, n chain specific, and affinity purified 
rabbit anti-mouse IgG, heavy and light chain specific, were obtained from 
Cappel Lab (Cochranville, PA). Rabbit anti-rat was obtained from Zymed 
Laboratories, Inc. (South San Francisco, CA). A summary of the second 
antibodies used in this dissertation are shown in Table 4b. Except where 
noted, protein A-g-galactosidase was obtained from Zymed Laboratories. 
Determination of Cell Number of Preimplantation Embryos 
The number of cells per embryo was determined by the Tarkowski method 
of air-drying mouse embryos (Tarkowski, 1966). Embryos were washed clean 
of culture medium and placed in 0.8% sodium citrate for 5 to 15 minutes at 
room temperature. Next, the embryos were transferred to a clean slide and 
0.02 ml drops of freshly prepared fixative (3 parts absolute methanol: 1 
part glacial acetic acid) were added. The preparations were stained in 
Giemsa (GIBCO), and the nuclei were counted at 400x magnification with a 
Zeiss phase contrast microscope. 
Cell Cytotoxicity Assay 
Congenic antisera were tested for reactivity in a complement mediated 
cytotoxicity assay. The assay was performed in a 96-well round bottom 
tissue culture plate (Dynatech). Each test well contained 10 pi of 6 x 
10® cells/ml tumor cell suspension, 10 nl serially diluted antisera, and 
10 ul of guinea pig complement diluted 1:2. All serum and cell dilutions 
were done in RPMI 1640 (GIBCO) containing 10% fetal calf serum. Normal 
mouse serum, diluted 1:4, was used as a negative control and rabbit anti-
mouse serum, diluted 1:4, was used as a positive control. The wells were 
mixed on an ELISA plate shaker (Dynatech, Torrance, CA) and incubated for 
1 hour at SJ^C. Following incubation the plate was placed on ice and 10 
nl of 0.4% trypan blue (GIBCO) were added to each well. The numbers of 
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live and dead cells were determined by counting the cell suspensions in a 
hemacytometer. Live cells exclude trypan blue dye while dead cells do 
not. The assay was performed in duplicate with a minimum of 200 total 
cells scored. Results were reported as percent dead cells compared to the 
total number of cells, as follows: 
% cytotoxicity = [(No. of dead cells in experimental wells)/(Total 
No. of cells)] - [(No. of dead cells in wells treated with the nega­
tive control antibody or normal mouse serum)/ (Total No. of cells in 
the control well)]. 
Cell Enzyme-linked Immunosorbent Assay (ELISA) 
The ELISA procedure used was modified from Lansdorp et al. (1980). 
The wells of a 96-well, round bottom tissue culture plate (Immunlon II, 
Dynatech) were treated with 200 nl of 0.1 g/1 poly-L-lysine (Sigma), for 
30 minutes to 1 hour at room temperature (RT). (Irranulon II plates were 
used instead of Immulon I plates because as they were found to bind cells 
better.) The wells were washed 3 times with PBS and 50 nl of P815, RDM-4 
or EL-4 cells at 5 x 10® cells/ml in PBS, were added to each well. Cells 
were allowed to settle for 1 hour at RT, at which time they were fixed to 
the plate by addition of freshly prepared 0.025% glutaraldehyde in PBS. 
Following a 10 minute incubation period, the wells were washed 3 times 
with PBS, and 200 nl of 200 mg/ml gelatin containing 1.0% sodium azide in 
PBS were added. Plates were stored with the final buffer in them, at 40C, 
until they were used. They were washed one time before use. 
The cell ELISA was performed by addition of 100 nl of antibody to 
wells containing fixed cells. The plates were incubated for 1.5-2 hours 
at 370c. Following incubation, wells were washed 3 times with PBS and 1 
time with 0.2% Tween-20 in PBS (PT). The appropriate second antibody 
(rabbit anti-rat, rabbit anti-mouse IgG, heavy and light chain specific or 
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rabbit anti-mouse IgM, u chain specific) was added, 50 ul/well at a 1:200 
dilution in assay buffer [lOmM Tris-HCl, lOmM NaCl, ImM MgCl2> 10% IgG 
free fetal calf serum (GIBCO), pH 7.5] and the plates were incubated for 1 
hour at 370C. The washing procedure was repeated and 50 nl of protein A-
g-galactosidase (Zymed), at a 1:400 dilution in assay buffer, were added 
to each well. The plates were incubated for 1 hour at 370C and the wash­
ing step was repeated. Substrate solution was made up fresh at 4 rag/ml of 
assay buffer to which 0.71 nl/ml of g-mercaptoethanol (BioRad, Richmond, 
CA)/ml had been added. o-Nitrophenyl-g-D-galactopyranoside (Sigma) was 
used as the substrate. After addition of 100 nl of substrate per well, 
plates were incubated at 370C for 1 hour. The reaction was stopped by 
addition of 100 nl of O.IM Na2C03 and the color Intensities were measured 
spectophotometrically at 410 nm. 
Embryo ELISA 
All manipulations with embryos were done in two well (0.5 ml volume) 
depression slides, using finely drawn pipets and a Bausch and Lomb dis­
secting microscope. Embryos were washed free of culture medium with PBS 
and Incubated at RT for 2 to 3 hours with either Ml/42, 53-7, 11-4.1, B8-
24-3, N-S.2.1, N-S.8.1 or 03.262 diluted to the appropriate concentration 
in PBS. The excess antibody was removed by washing the embryos 3 times in 
PBS and 1 time with PT. Embryos were then incubated for one hour at RT in 
the proper second antibody (rabbit anti-mouse IgG, heavy and light chain 
specific, rabbit anti-mouse IgM, m chain specific,, or rabbit anti-rat) di­
luted 1:100 in assay buffer. Following the incubation period, the embryos 
were washed three times in PBS, one time in PT and incubated for 1 hour in 
Protein A-g-galactosidase diluted 1:50 in assay buffer. After the wash­
ing procedure had been repeated, the embryos were added to 100 ul of sub­
strate solution and incubated for 1 hour at 370C. The number of embryos/ 
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well was dependent on the stage of development; in general blastocyst 
stage embryos were placed 5/well, 8 cell stage embryos were placed 
10/well, 2 cell stage embryos were placed 20/well and 1 cell stage embryos 
and oocytes were placed 40/well. The reaction was stopped by the addition 
of O.IM Na2C03, and the color intensities were measured spectrophotometri-
cally at 410 nm. This assay has been described in detail in Goldbard et 
al. (1984). When multiple experiments were performed, as in the develop­
ment curves, the experiments were normalized to a common point. Normali­
zation was done by calculating a correction factor for each experiment, 
after chosing one experiment as the standard experiment. The standard 
experiment was given a correction factor of one, remaining correction 
factors were calculated according to the following equation: 
Correction Factor = [Mean of the A410 of the values in the common 
point of the standard experiment]/ [Mean of the A41Q of the values of 
the common point of the experiment being normalized] 
Each replicate in the experiment was multiplied by the correction factor. 
Embryo Cytotoxicity Assay 
The assay was performed according to the procedure described by Cozad 
and Warner (1981) and Cozad et al. (1981) with only small modifications. 
Ten 8-cell embryos were placed in 50 nl of either Brinster's or Whitten 
and Biggers' medium in one well of a 96-well, flat bottom plate 
(Dynatech), and 50 ul of the appropriate antibody dilution were added. 
Plates were then incubated for one hour at 370C and 5% CO2 in air. 
Following the incubation period, 50 ul of a 1:2 dilution of fresh guinea 
pig complement were added. After a one hour incubation period, 150 ul of 
8 uCi/ml ^H-thymidine [(methyl-3)-thymidine, 20 Ci/mM, New England 
Nuclear) in either culture medium were added, and the plates were in­
cubated overnight. The contents of the wells were then harvested using a 
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Titertek cell harvester. The experimental data were corrected by subtrac­
tion of the background cpm. Viable embryos incorporate ^h-thymidine, but 
embryos killed by antiserum and complement do not. Thus, the assay is a 
measure of embryo viability. 
Segregation Analysis of Fed Gene Expression 
Detection of H-2 antigens on backcross embryos 
A backcross generation was produced as described in Figure 2. Em­
bryos from the backcross generation were collected at 93 hours post-hCG in 
Whitten and Biggers' medium and were either H-2 typed immediately or 
transferred into pseudopregnant females as described below. Embryos were 
H-2 typed using either 11-4.1 (anti-H-2k) or B8-24-3 (anti-H-2b) diluted 
1:10 in PBS as the primary antibody in the embryo ELISA described above. 
N-S.8.1 was used as a negative control in these experiments. 
Transfer operation and typing of offspring In the second set of ex­
periments, embryos were collected from the backcross generation in Whitten 
and Biggers' medium at 93 hours post-hCG, separated into morulae and 
blastocysts, and the blastocyst stage embryos were transferred into 
psuedopregnant females. Embryos were allowed to develop to term and the 
neonates were collected on the day of birth. The liver or thymus was 
removed from each pup and treated with 0.25% trypsin (GIBCO) in Dulbecco's 
PBS at 370c for 20 minutes. After the trypsin solution was removed by 
centrifugation, the cells were washed first in.RPMI 1640 containing 10% 
PCS and then in Dulbecco's PBS. Next the cells were fixed to the wells of 
a 96-well tissue culture plate (Dynatech), which had been pretreated with 
200 nl of 0.1 g/1 solution of poly-L-lysine/well for 30-60 minutes, by the 
addition of 0.025% glutaraldehyde in PBS. Following a 20 minute incuba­
tion period, cells were washed three times in PBS and 200 ul of blocking 
solution (200 mg/ml gelatin in PBS containing 1.0% sodium azide) were added 
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Generation of Fj: 
C57BL/10Sn 
(H-2b,Pedfast) 
X 810.BR 
(H-2k, PedSlow) 
(C57BL/10Sn X B10.BR)Fi 
(H-2bk, Pedfast) 
Generation of Backcross: 
(C57BL/10Sn X B10.BR)Fi X BIO.BR 
50% slow 
(morulae) 
Predicted H-2 
genotype: bk kk 
Figure 2. Experimental plan for segregation studies of the Ped gene 
Predicted rate 
of development: 50% fast 
(blastocysts) 
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to each well. Plates were stored at 4®C until use. 
H-2 typing was done by the cell ELISA described above. Either 11-4.1 
(anti-H-2k), B8-24-3 (antiH-2b) or N-S.8.1 (negative control) diluted 1:50 
in PBS was used as a primary antibody. Affinity purified rabbit anti-
mouse IgG, heavy and light chain specific, diluted 1:200 in assay buffer 
was used as a second antibody. 
Enzyme Treatment of Embryos 
Pronase treatment time course 
An initial time course study was done to determine the optimum enzyme 
treatment period. CFl blastocyst stage embryos were treated with pronase 
[Sigma, 0.5% solution in Whitten and Biggers' medium without bovine serum 
albumin (BSA, GIBCO)] for 2, 5, 7, and 10 minutes. After each time point, 
embryos were removed from the enzyme medium and wash'ed twice in Whitten 
and Biggers' medium and twice with PBS before using them in the embryo 
ELISA procedure described above. 
H-2 antigen removal and recovery experiments 
H-2 antigen removal and recovery experiments were performed by treat­
ing CFl blastocysts stage embryos, which had been pretreated with Tyrode's 
solution according to Thadani (1982) to remove the zonea pellucidae, with 
either pronase or papain. 
Pronase treatment CFl blastocyst stage embryos were treated for 
6 minutes with either a 0.5% solution of pronase in Whitten and Biggers' 
medium without BSA, or in Whitten and Biggers' alone (no treatment con­
trols). Following treatment the embryos were washed with Whitten and 
Biggers' medium and PBS as described above and used in the ELISA proce­
dure. Part of the pool of treated embryos were washed and incubated for 3 
hours at 370C in 5% CO2 before the ELISA procedure was performed (recovery 
controls). The same procedure was used with P815 cells. 
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Papain treatment Removal of H-2 antigens with papain was per­
formed according to the method of Gromkoski et al. (1983). Zonae-free 
embryos were treated with enzyme treatment medium [ETM (pH 7.4): Earle's 
balanced salt solution (GIBC0)/15 mM HEPES/ 20mM L-cysteine/ 1% PCS/ 
3 mg/ml papain (Sigma)] for 30 minutes, after which they were washed and 
used in the ELISA procedure. No treatment controls were embryos treated 
with enzyme free ETM. After enzyme treatment, some embryos were washed 
and incubated for 3 hours at 37^0 in 5% COg. The same procedure was used 
for P815 cells except they were washed and incubated in tissue culture 
medium A. 
Inhibition of Embryonic Development By Anti-Qa-2 Antibody 
Embryos were collected at 65 hours post-hCG (8-cell stage) in 
Brinster's medium and incubated overnight in 100 nl of the appropriate 
dilutions of purified D3.262, N-S.2.1 or B8-24-3 antibody in 96-well flat 
bottomed tissue culture plates (Dynatech). Antibodies were diluted in 
Brinster's medium. Following Incubation, the embryos were washed with 
Brinster's medium and their ability to Incorporate ^H-thymidine was mea­
sured by adding 100 ul of 8 uCi/ml ^H-thymidlne in Brinster's medium for a 
24 hour incorporation period. Following the incubation period, the plates 
were placed on ice and the contents of the wells were harvested using a 
Titetek cell harvester. 
H-2 Antigen Isolation 
Cell iodination 
Lactoperoxidase-catalyzed iodination, as described in Phillips and 
Morrison (1971), was used to label cell surface proteins. Tumor cells 
were collected from spinner cultures by centrifugation at 800 x g for. 10 
minutes; a total of 1 x 10® cells were used for each Iodination. The 
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cells were washed free of culture medium with phosphate buffered Earle's 
balanced salt solution (PBESS, GIBCO), and brought to a final concentra­
tion of 6.67 X 108 cells/ml PBESS. The iodination procedure was carried 
out in the vial of a combi-V-vial containing 5 mCi of low pH, high conce­
ntration, carrier free 125% (New England Nuclear, Boston, MA) and 10 nl of 
lOjiM sodium sulfite. Following the addition of the cells, 200 ng of lac-
toperoxidase (Sigma) were added. The labeling reaction was started with 
the addition of 100 nl of l.SmM H2O2 (Sigma). An additional 400 ul of 
H2O2 was added in 100 ul aliquots at 2 minute intervals. After the final 
H2O2 addition the reaction was allowed to rest for 5 minutes. The cells 
were then washed four times in PBESS. Incorporation of label was 1 to 4 
cpm per eel1. 
Cell lysis 
Cell lysis was done according to the procedure described by Stall cup 
et al. (1981) with a few modifications. Cells were collected from spinner 
cultures and washed free of culture medium with four washes of PBESS. 
Cells were lysed at 2 x 10^ cells/ml in 0.5% Triton X-100 , 20mM Tris, pH 
8.0 (Triton-Tris buffer) containing l.SmM phenylmethylsulfonylfloride 
(PMSF, Sigma). After 10 minutes on ice, the nuclei were pelleted by cen-
trifugation at 3600 x g (low speed centrifugation) for 15 minutes. The 
resulting pellet was resolubilized in an equal volume of Triton-Tris buf­
fer for 10 minutes on ice. A second low speed centrifugation was done and 
the supernatants from the low speed spins were combined and centrifuged at 
100,000 X g for 45 minutes (high speed centrifugation). The supernatant 
from the high speed spin was collected and used in subsequent purification 
steps. 
Affinity chromatography 
Column preparation Affinity columns were prepared using CNBr-
activated Sepharose 4B (Pharmacia, Piscataway, NJ) and purified monoclonal 
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antibodies, according to the product insert. Dry CNBr activated-Sepharose 
4B was swollen in 1 mN HCl for 15 minutes at RT and washed in 200 ml of 1 
mM HCl/ gm of dry gel. After the final wash, the gel was placed in 0.1 M 
NaHCOs, pH 8.0 (coupling buffer) and 2.5 mg of purified antibody/ml of gel 
was added. The coupling reaction was carried out for 2 hours at RT on an 
end over end rotator. Following the coupling reaction, excess antibody 
was washed away with coupling buffer and the remaining active groups were 
blocked by treatment of the gel with O.IM Tris-HCl buffer, pH 8.0, for 1 
hour at RT. Noncovalently bound material was removed by washing the gel 
four times by alternating O.IM acetate buffer, pH 4.0, 0.5M NaCl, and 
coupling buffer. The coupled gel was stored in Triton-Tris buffer at 4^0 
until use. 
Chromatography Labeled and unlabeled cell lysates were combined 
and rotated end over end with Sepharose 4B (Sigma) at 4^0 overnight. 
Pretreated lysate was then added to the antibody-Sepharose 4B gel and 
rotated overnight. The unbound material was washed from the gel with 
Triton-Tris buffer. Washing was done until the cpm of the washes was 
equal to the background cpm. The gel with bound antigen was then poured 
into a column and 0.5% deoxycholate in 20mM Tris, pH 8.5, 0.65M NaCl (elu-
tion buffer) was added. Fractions of 1 ml were collected and the amount 
of radioactivity per fraction was determined. Peak fractions were pooled 
and immediately dialyzed against 0.3% deoxycholate in 20mM Tris, pH 8.5, 
0.15M NaCl. Samples were taken for protein determination by the method of 
Lowry et al. (1959), and the remaining H-2 antigens were frozen until 
further use. 
Gel electrophoresis and autoradiography 
Samples containing 10-20 ng of protein were precipitated by the addi­
tion of 6 volumes of cold acetone and incubation at -20^0 for 14 hours, 
for subsequent analysis by sodium dodecyl sulfate (SDS) polyacrylamide gel 
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electrophoresis. Electrophoresis was done by the method of Laenanli 
(1970), in the presence of SDS and g-mercaptoethanol. The running gel 
consisted of 12% polyacrylamide (BioRad) with a 4% polyacrylamide stacking 
gel. Gels were stained with Coomassie Blue and autoradiography was done 
using Kodax XR-5 X-ray film. 
Blocking Studies 
Cell ELISA 
Blocking studies were done by the addition of 50 nl of purified H-2 
antigen, diluted in Triton-Tris buffer, to wells of a 96-well tissue cul­
ture plate (Dynatech) which had tumor cells fixed to them. Immediately 
following the addition of antigen, 50 nl of a 1:200 dilution of a 1 mg/ml 
solution of antibody was added and the cell ELISA procedure was performed 
as described above. Control wells contained either antigen and cells 
alone or antibody, Triton-Tris buffer, and cells. 
Embryo ELISA 
Blocking studies on embryos were performed by placing blastocyst 
stage embryos from either BIO.BR (H-2k) or C57BL/6 (H-2^) mice in depres­
sion slides containing 50 ul of either 11-4.1 (anti-H-2k) or B8-24-3 
(anti-H-2b) monoclonal antibody, at a concentration of 0.1 mg/ml. Fol­
lowing a two hour incubation at RT, the embryos were washed with PBS and 
PT as described above, and the embryo ELISA was done, beginning with the 
addition of the second antibody, rabbit anti-mouse IgG, heavy and light 
chain specific. Protein A-g-galactosidase was used at a 1:50 dilution and 
substrate was used at 4 mg/ml. 
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RESULTS 
Development of the Cell ELISA 
An enzyme linked immunosorbent assay (ELISA) was developed to detect 
H-2 antigens on tissue culture cells. The assay was adapted from Lansdorp 
et al. (1980). Two different ELISA systems were developed. The first 
(cell ELISA I) used rat anti-mouse antibody as the primary antibody and 
rabbit anti-rat antibody as the secondary antibody, as diagrammed in Fig. 
3. The second (cell ELISA II) used mouse anti-mouse antibody as the pri­
mary antibody and rabbit anti-mouse antibody (heavy and light chain spe­
cific) as the secondary antibody, as diagrammed in Figure 4. Both assays 
utilized the manufacturer's suggested dilution of protein A-g-galacto-
sidase, 1:400, and a substrate concentration of 4 mg/ml. The parameters 
for each assay were selected. Cell ELISA I used the Ml/42 monoclonal 
antibody, a rat-mouse hybridoma (Stallcup et al., 1981), because it reacts 
with all H-2 haplotypes. The Sephadex G-200-elution profile for Ml/42 
monoclonal antibody, purified from the supernatant of cells by ammonium 
sulfate precipitation, is shown in Figure 5. Also shown in the same fig­
ure is the activity of the different fractions in an ELISA on P815 cells. 
It is seen that the protein and activity profiles coincide. The 53-7 cell 
line was chosen as a negative control, since it is also a rat-mouse hybri­
doma and its antibody is directed to the Ly 1.2 antigen present only on 
thymus or T cell subpopulations. The 53-7 monoclonal antibody was puri­
fied through the same procedure as the Ml/42 monoclonal antibody. The 53-
7 elution profile and reactivity with EL-4 cells (T lymphoma cells) in an 
ELISA is shown in Figure 6. 
The data in Figures 7 and 8 show the selection of suitable dilutions 
of the Ml/42 antibody and the rabbit anti-rat antibody. To conserve rea­
gents the final concentrations chosen were 1:100 for Ml/42 and 1:200. for 
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Cell ELISA I 
A-
Protein A-
>S-galactosidase 
Ml/42 
(Rat anti-mouse 
monoclonal antibody) 
Colorless 
substrate 
Yellow 
product 
I Rabbit anti-rat antibody 
Mouse lOOOOOOOOOOOTDl ë'eTs' 
Figure 3. Schematic diagram of cell ELISA I 
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Figure 4. Schematic diagram of cell ELISA II. 
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Figure 5. Elution and activity profiles of monoclonal antibody Ml/42. 
The activity of the monoclonal antibody was measured using 
P815 cells in cell ELISA I. Rabbit anti-rat antibody was used 
at a 1:200 dilution and protein A-g-galactosidase at a 1:400 
dilution 
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Figure 6. Elution and activity profiles of monoclonal antibody 53-7. 
The activity of the monoclonal antibody was measured using EL-
4 cells in cell ELISA I. Rabbit anti-rat antibody was used at 
a 1:200 dilution and protein A-g-galactosidase at a 1:400 
dilution 
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Figure 7. Titration of Ml/42 monoclonal antibody. Ml/42 was used in the 
cell ELISA I. P815 cells were used as target cells. Rabbit 
ant-rat was used at a 1:200 dilution and protein A-g-galacto-
sidase at a 1:400 dilution. Results are reported as A^^o per 
well and are adjusted by subtraction of the A^JQ of wells 
treated with PBS; each dilution was tested in duplicate and the 
standard deviations are shown 
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Figure 8. Titration of rabbit anti-rat antibody. The cell ELISA I was 
performed using the Ml/42 (•) or 53-7 (o) monoclonal antibodies 
at a 1:100 dilution and protein A-g-galactosidase at a 1:400 
dilution. P815 cells were used as target cells. Results are 
reported as A^^o P®*" well; each dilution was tested in du­
plicate and the standard deviations are shown as error bars 
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the rabbit anti-rat antibody. 
Next, the parameters for cell ELISA II were selected. In order to 
detect monoclonal antibodies of all IgG isotypes (?!, Y2a» T2b AND YS)» 
rabbit anti-mouse antibody that was specific for both heavy and light 
chains was used. Data are shown for the optimization of the concentration 
of rabbit anti-mouse IgG, heavy and light chain specific, antibody (Figure 
9). In this experiment a mouse alloantiserum was used at a 1:200 dilu­
tion. In subsequent experiments, described later, either mouse alloanti-
sera or monoclonal antibodies were used at appropriate dilutions. Again, 
in order to conserve reagents, a low antibody dilution was chosen, in this 
case, a 1:200 dilution of rabbit anti-mouse antiserum. 
To test the sensitivity of the ELISA procedure, cell ELISA II was 
used. Figure 10 shows the titration curve of CBA anti-DBA/2 (anti-H-2d) 
antiserum on F815 cells (H-2d). These results show that the ELISA is able 
to detect the presence of H-2 antigens at a 1:3200 dilution. When this is 
compared to the cell cytotoxicity assay. Figure 11, it is seen that the 
ELISA is at least 2000 times more sensitive than the cytotoxicity assay. 
Development of the Embryo ELISA 
The first embryo ELISA procedure (embryo ELISA I) was adapted from 
cell ELISA I, which was described in Figure 3. Embryo ELISA I is dia­
grammed in Figure 12. For development of embryo ELISA I, two parameters 
needed to be obtained, the concentration of rabbit anti-rat antibody and 
the concentration of protein A-g-galactosidase. For these experiments, 
the Ml/42 monoclonal antibody was used at a concentration of 0.1 mg/ml 
(1:10 dilution of stock solution) and the substrate at 4 mg/ml. Figure 13 
shows the titration curve of rabbit anti-rat antibody on CFl embryos. 
Figure 14 shows the titration curve of protein A-g-galactosidase on CFl 
embryos. From these experiments, it was concluded that the optimal dilu-
Figure 9. Titration of rabbit anti-mouse IgG, heavy and light chain specific, antibody. P815 
2") tumor cells were used as targets for CBA anti-DBA/2 (anti-H-E^) serum, diluted 1:200, 
(•) or normal mouse serum (o), diluted 1:200, in cell ELISA II; protein A-g-galactosidase 
was used at a 1:400 dilution. Results are reported as A^^Q per well; each dilution was 
tested In duplicate and standard deviations are shown for each point as error bars 
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Figure 10. Titration curve of CBA ant1-DBA/2 (ant1-H-2^) serum. Cell ELISA II was performed using 
P815 (H-2") cells as target cells and rabbit anti-mouse, heavy and light chain specific, 
at a 1:200 dilution and protein A-g-galactosldase at a 1:400 dilution. Results are 
reported as A^^Q well; each dilution was tested In duplicate and standard deviations are 
shown for each point as error bars 
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Figure 11. Titration curve of CBA anti-DBA/2 (anti-H-Z**) serum against 
P815 tumor cells (H-2^) using the cell cytotoxicity assay. 
Results are reported as percent cytotoxicity, calculated as 
described in Material and Methods 
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Figure 12. Schematic diagram of embryo ELISA I 
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Figure 13. Titration of rabbit anti-rat antibody. Embryo ELISA I was 
performed using the Ml/42 monoclonal antibody (^) at a 
concentration of 0.1 mg/ml, or PBS (a). Protein A-g-galacto-
sidase was used at a 1:50 dilution. Results are reported as 
A^IQ per 5 CFl blastocysts. Dilutions were tested in du­
plicate and the standard deviations are shown as error bars 
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Figure 14. Titration of protein A-e-galactosidase. Embryo ELISA I was 
performed using Ml/42 monoclonal antibody (•) at a 0.1 mg/ml 
concentration or PBS (n). Rabbit anti-rat antibody was used 
at a a 1:100 dilution. Results are reported as per 5 CFl 
blastocysts. Dilutions were tested in duplicate and the stan­
dard deviations of each point are shown 
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tiens to be used would be 1:100 of rabbit anti-rat antibody and 1:50 of 
protein A-g-galactosidase. In the case of the rabbit anti-rat antibody, 
the 1:100 dilution was chosen over the 1:50 dilution because of the lower 
background. 
The effect of removing the zonae pellucidae from the embryos on em­
bryo ELISA I was assessed by comparing zonae-free embryos (previously 
treated with Tyrode's solution, see Materials and Methods) with intact 
embryos. It can be observed from Figure 15 that removal of the zonae 
enhanced absorbance in the ELISA, probably indicating an increased access 
of the antibody to the embryonic cells. However, removal of the zonae 
also resulted in weakening the embryos, often causing them to disintegrate 
during the assay. For this reason, the assay was generally performed on 
intact embryos. 
In order to determine the sensitivity of embryo ELISA I, the Ml/42 
monoclonal antibody was titrated. The 53-7 antibody, described pre­
viously, was used as a negative control. It can be seen in Figure 16 that 
Ml/42 binds specifically to the embryos. The 53-7 monoclonal antibody did 
not show any reactivity to the embryos. This was expected because anti­
body 53-7 is directed to a thymus cell differentiation antigen (Ly 1.2), 
not likely to be present in early development. 
The Ml/42 monoclonal antibody was used to compare the embryo ELISA 
method with the embryo cytotoxicity assay. It can be seen from Figure 17 
that while in the cytotoxicity assay the optimal antibody dilution was 
1:10 or lower, in the embryo ELISA it was 1:100. 
The second embryo ELISA procedure (embryo ELISA II) was adapted from 
the cell ELISA II, which was described in Figure 4. Embryo ELISA II is 
diagrammed in Figure 18. In order to determine if the second antibody was 
necessary, or if protein A-g-galactosidase alone would provide adequate 
assay sensitivity, the assay was done in the absence of the second anti-
Figure 15. Effect of zona pellucida removal on the ELISA 
method. A comparison of H-2 antigen level detection 
on CFl blastocysts with (dark bar) and without (open 
bar) the zona pellucida is shown. Ml/42 monoclonal 
antibody at a 0.1 mg/ml concentration, was used at 
the primary antibody; rabbit anti-rat antibody was 
used at a 1:100 dilution and protein A-g-galacto-
sidase at a 1:50 dilution. Results are reported as 
A410 per 5 embryos and are adjusted by subtraction 
of the A410 of embryos treated with PBS. Each test 
was done in duplicate and the standard deviations 
are shown as error bars 
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Figure 16. Titration of Ml/42 monoclonal antibody on CFl blastocysts. 
Embryo ELISA I was performed using Ml/42 monoclonal antibody 
(•), 53-7 monoclonal antibody (o) or PBS {•). Rabbit anti-rat 
antibody was used at a 1:100 dilution and protein A-g-galacto-
sidase at a 1:50 dilution. Results are reported as A^^o 5 
embryos; each dilution was tested in duplicate and the stan­
dard deviations are shown as error bars 
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Figure 17. Comparison of embryo ELISA I (A) with the embryo 
cytotoxicity assay (•) using the Ml/42 monoclonal antibody 
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Figure 18. Schematic diagram of embryo ELISA II 
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body. The second antibody increases the sensitivity of the reaction 6 
fold, without increasing the background levels dramatically (see Figure 
19). Therefore, the second antibody was always included in the assay. 
The details of the reaction parameters used for embryo ELISA II are de­
scribed in the next section. 
Detection of MHC Antigens on Early Embryos 
Class X antigen detection 
H-2 region The expression of H-2 antigens by mouse embryos during 
development was detected using embryo ELISA I and embryo ELISA II. Ini­
tial experiments were done using the Ml/42 monoclonal antibody (embryo 
ELISA I) to detect all H-2 class I antigens on CFl embryos. The results 
in Figure 20 are plotted as absorbance per embryo and show that class I 
antigens are present on unfertilized eggs, and on embryos at all stages of 
development, although levels are quite low early in development. Because 
the number of cells per embryo increases with development, in order to 
accurately compare the amount of H-2 antigens per embryo, the results were 
calculated on a per cell basis (Table 5). Moreover, because the ELISA 
reagents cannot penetrate the blastocoel and are, therefore, detecting H-2 
antigens only on the outer cells of the embryos, the results were also 
calculated per "outside" cell. Recalculation on the basis of number of 
"outside" cells indicates that blastocyst stage embryos express equivalent 
amounts of H-2 antigens on their outside cells as do 8 cell stage embryos 
and that the amount of H-2 antigen per cell does not increase during de­
velopment. This is illustrated in Figure 21a. The amount of H-2 antigen 
expressed by oocytes is higher than that expressed by later embryonic 
stages (see Figure 21a) and may be due to expression of the maternal pool 
of mRNA. It is often difficult to separate unfertilized eggs from 1 cell 
embryos. Contamination of the 1 cell data by oocytes, could result in an 
Figure 19. Effect of a second antibody on the embryo ELISA II. 
A: Reactivity of the 11-4.1 (open bar), B8-24-3 
(light bar) and N-S.8.1 (dark bar) on BIO.BR 
blastocyst stage embryos in the absence of the 
second antibody. B: Reactivity of the 11-4.1 (open 
bar), B8-24-3 (light bar), and N-S.8.1 (dark bar) on 
BIO.BR blastocyst stage embryos. Rabbit anti-mouse, 
heavy and light chain specific, antibody was used at 
a 1:100 dilution. In both experiments protein-A-g-
galactosidase at a 1:50 dilution. Results are 
presented as A410 per 5 embryos. A minimum of 10 
embryos was used for each point; standard deviations 
are shown as error bars 
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Figure 20. Detection of H-2 antigens on preimplantation mouse embryos ( ) 
and oocytes (•) with the Ml/42 monoclonal antibody in embryo 
ELISA I. Rabbit anti-rat antibody was used at a 1:100 dilu­
tion, protein A-B-galactosidase at a 1:50 dilution. Results 
are reported as A410 per embryo and were adjusted by subtrac­
tion of the A410 of embryos treated with PBS. A minimum of 20 
embryos were used for each point and the standard errors 0 
the means are represented as error bars 
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Figure 21a. Expression of H-2 antigens by preiraplantation mouse embryos 
(o) and oocytes (•). Results are reported as per out­
side cell, and were calculated from the values shown in 
Figure 20 and Table 5 
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Figure 21b. Reactivity of 11-4.1 (anti-H-2Kk on RDM-4 (H-2^) and EL-4 (H^ 
cells. Cell ELISÀ II was performed using 11-4.1 mono­
clonal antibody on RDM-4 cells (o) or EL-4 (•). Rabbit anti-
mouse, heavy and light chain specific, antibody was used at a 
1:200 dilution and protein A-g-galactosidase at a 1:400 dilu­
tion. Results are reported as per well and were ad­
justed by subtraction of the A^JQ of wells treated with PBS. 
Standard deviations are shown as error bars 
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Table 5. Expression of H-2 antigens during development 
ELISA Results 
Time 
post-hCG 
(hrs) 
Mean cell 
No./Embryo 
(S.E.)a 
No. of 
"outside" 
blastomeres 
Mean A410 Per 
Embryo Cell 
"outside" 
cell 
17 (oocyte) 1.0(0.0) 1 0.012 0.012 0.012 
17 (1 cell) 1.0(0.0) 1 0.010 0.010 0.010 
41 (2 cell) 2.0(0.0) 2 0.007 0.004 0.004 
65 (8 cell) 6.8(0.3) 6.8 0.032 0.004 0.004 
89 (blastocyst) 39.3(1.8) 19b 0.070 0.002 0.004 
^Determined by the Tarkowski method (Tarkowski, 1966). A minimum of 
30 embryos were scored for each point. 
''Extrapolated from Handyside (1981). 
appearance of higher H-2 expression by the 1 cell stage embryos. For this 
reason, future experiments often did not include data from the 1 cell 
stage. 
Because the Ml/42 monoclonal antibody detects all H-2 class I anti­
gens, two other monoclonal antibodies were used to follow the expression 
of specific H-2 class I antigens. For these studies, embryo ELISA II was 
used. The 11-4.1 monoclonal antibody is a mouse monoclonal antibody spe­
cific for the H-2Kk antigen. It was used to follow the expression of this 
antigen on BIO.BR (H-2k) embryos. The reactivity of this antibody on RDM-
4 (H-2k) cells and EL-4 (H-2b) cells is shown in Figure 21b. The antibody 
exhibits little crossreactivity with H-2b antigens. The reactivity of the 
11-4.1 monoclonal antibody on BIO.BR and C57BL/10J (H-2b) embryos is shown 
in Figure 22a; the antibody does not react with embryos of the H-2b haplo-
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Figure 22a. Reactivity of the 11-4.1 monoclonal antibody (anti- H-2K'^) on 
BIO.BR (•) and C57BL/10 (a) blastocyst stage embryos. Embryo 
ELISA II was performed using the rabbit anti-mouse, heavy and 
light chain specific, antibody was used at a 1:100 dilution 
and protein-A-g-galactosidase at a 1:50 dilution. Results 
are reported as per 5 embryos and are adjusted by sub­
traction of the A^JQ of embryos treated with the control 
antibody, N-S.8.1. Each dilution was tested in duplicate and 
the standard deviations are shown as error bars 
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Figure 22b. Titration of rabbit anti-mouse IgS, heavy and light chain 
specific. Embryos ELISA II was performed using either the 
11-4.1 monoclonal antibody or the N-S.2.1 monoclonal antibody 
at a 0.1 mg/ml concentration. Protein A-g-galactosidase 
(Sigma) was used at a 1:100 dilution. Results are reported 
as A41Q per 5 BIO.BR blastocysts. Dilutions were tested In 
duplicate and the standard deviations are shown as error bars 
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type at a 1:10 dilution, but shows some binding at a 1:5 dilution. There­
fore, it was decided the 11-4.1 antibody would be used at a 1:10 dilution. 
The other parameters in the assay were rabbit anti-mouse IgG, heavy and 
light chain specific, antibody at a 1:100 dilution, protein A-g-galacto-
sidase at a 1:50 dilution and substrate at 4 mg/ml. (The titration curve 
of rabbit anti-mouse IgG, heavy and light chain specific, was done at a 
later date, using protein A-g-galactosidase obtained from Sigma, as shown 
in Figure 22b. This curve suggests that a 1:100 dilution of second anti­
body was indeed optimal for this assay.) The expression of the H-2K'^ 
antigen per embryo is shown in Figure 23; in this experiment the N-S.8.1 
monoclonal antibody was used as a negative control. The data for this 
graph were obtained in 6 experiments as shown in Table 6a, and were nor­
malized (see Table 6b) according to the formula in the Materials and 
Methods. It is necessary to normalize the results because of the variabi­
lity seen between experiments (see Table 6a). The results show an Increase 
in H-2^ antigen on a per embryo basis. In Table 7, the results are cal­
culated on a per cell basis and per "outside" cell basis, as was done for 
general H-2 antigen expression (see Table 5). When the results were cal­
culated in this manner, it is seen that the H-2K'^ antigen decreases from 
the oocyte stage to the 2 cell stage, at which point H-2 expression levels 
out. This is shown in Figure 24a. 
The B8-24-3 monoclonal antibody is specific for the H-2K^ antigens, 
but crossreacts with the ti-2^ antigens as shown in Figure 24b. The ti­
tration of this antibody on C57BL/6 blastocyst stage embryos is shown In 
Figure 24c and Its reactivity on C57BL/10J (H-2^) blastocysts and BIO.BR 
(H-2*^) blastocysts is shown in Figure 25. The antibody also crossreacts 
with H-2k antigens on embryos at low dilutions. A 1:10 dilution of the 
antibody was chosen for further experiments. The expression of the H-2K^ 
antigen by C57BL/6 embryos was determined with the embryo ELISA II, using 
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Table 6a. Experiments detecting H-2Kk antigens on BIO.BR embryos® 
Experiment Stage Antibody 
No. Of 
embryos/ A^ig/ 
Well Well Embryo 
Normalized 
A410/ 
Embryo 
1 Oocytes N-S.2.1 30 0.59 0.020 0.020 
30 0.28 0.009 0.009 
15 0.10 0.007 0.007 
11-4.1 30 1.87 0.062 0.062 
30 1.67 0.056 0.056 
30 1.43 0.048 0.048 
8 cell N-S.2.1 10 0.57 0.057 0.057 
11 0.50 0.045 0.045 
11-4.1 11 0.20 0.018 0.018 
11 0.19 0.017 0.017 
Blastocyt N-S.2.1 5 0.02 0.004 0.004 
5 0.03 0.006 0.006 
5 0.00 0.000 0.000 
5 0.00 0.000 0.000 
5 0.00 0.000 0.000 
11-4.1 5 0.52 0.104 0.104 
5 0.39 0.078 0.078 
5 0.36 0.072 0.072 
5 0.31 0.078 0.078 
11 1.16 0.091 0.091 
2 8 cell N-S.2.1 19 0.11 0.006 0.018 
11-4.1 17 0.23 0.015 0.045 
Blastocyst N-S.2.1 6 0.45 0.080 0.024 
6 0.00 0.000 0.000 
6 0.00 0.000 0.000 
6 0.00 0.000 0.000 
11-4.1 7 0.20 0.028 0.084 
3 Blastocyst N-S.2.1 5 0.02 0.004 0.012 
5 0.04 0.008 0.025 
11-4.1 5 0.08 0.016 0.049 
5 0.18 0.036 0.111 
5 0.15 0.030 0.092 
^Results were normalized to the blastocyst point in experiment 1, by 
the calculation shown in Table 6b. 
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Table 6a. cont.s 
Experiment Stage Antibody 
No. of Normalized 
embryos/ A420/ A410/ 
Well Well Embryo Embryo 
Blastocyst N-S.2.1 5 0.08 0.016 0.061 
5 0.05 0.010 0.038 
11-4.1 5 0.11 0.022 0.084 
2 cell N-S.2.1 20 0.08 0.001 0.004 
11-4.1 20 0.08 0.001 0.004 
8 cell N-S.2.1 15 0.02 0.001 0.004 
17 0.00 0.000 0.000 
11-4.1 10 0.05 0.005 0.022 
11 0.03 0.003 0.013 
Blastocyst N-S.2.1 5. 0.05 0.010 0.044 
5 • 0.01 0.002 0.009 
5 0.01 0.002 0.009 
5 0.01 0.002 0.009 
5 0.01 0.002 0.009 
11-4.1 5 0.13 0.026 0.115 
5 0.06 0.012 0.053 
2 cell N-S.2.1 23 0.00 0.000 0.000 
11-4.1 25 0.06 0.005 0.038 
Blastocyst N-S.2.1 5 0.02 0.003 0.023 
11-4.1 5 0.06 0.011 0.084 
^Results were normalized to the blastocyst point in experiment 1, by 
the calculation shown in Table 6b. 
the parameters described above.- The results shown in Figure 26 were ob­
tained in 2 experiments (see Table 8). The amount of H-2Kb antigen ex­
pressed on "outside" cells is shown in Table 9 and graphically in Figure 
27. The amount of H-2Kb antigen decreases from the oocyte to the 2 cell 
stage and continues to decrease through the 8 cell stage where the antigen 
expression appears to level off or increase slightly. 
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Table 6b. Calculation of the correction factors for the normalization of 
the experiments in Table 6 
Experiment 2: 
Mean of the A410 of the blastocyst point in expt. 1 
Correction Factor = 
Mean of the A410 of the blastocyst point in expt. 2 
(0.104 + 0.078 + 0.072 + 0.078 + 0.091)/5 
= = 3.01 
(0.028) 
Experiment 3: 
Mean of the A410 of the blastocyst point in expt. 1 
Correction Factor = 
Mean of the A410 of the blastocyst point in expt. 3 
= (0.104 + 0.078 + 0.072 + 0.078 + 0.091)/5 
= 3.08 
(0.016 + 0.036 + 0.030)/3 
Experiment 4; 
Mean of the A410 of the blastocyst point in expt. 1 
Correction Factor = 
Mean of the A410 of the blastocyst point in expt. 4 
= (0.104 + 0.078 + 0.072 + 0.078 + 0.091)/5 
= 3.82 
(0.022) 
Experiment 5: 
Mean of the A410 of the blastocyst point in expt. 1 
Correction Factor = 
Mean of the A410 of the blastocyst point in expt. 5 
= (0.104 + 0.078+ 0.072 + 0.078 + 0.091)/5 
= 4.43 
(0.026 + 0.012)/2 
Experiment 6: 
Mean of the A410 of the blastocyst point in expt. 1 
Correction Factor = 
Mean of the A410 of the blastocyst point in expt. 6 
= (0.104 + 0.078 + 0.072 + 0.078 + 0.091)/5 
= 7.69 
(0.011) 
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Figure 23. Detection of H-EK^ antigens on BIO.BR preimplantation embryos 
(o) and oocytes (•) with 11-4.1 monoclonal antibody (anti-H-
2K*) at a concentration of 0.1 mg/ml in embryo ELISA II. 
Rabbit anti-mouse, heavy and light chain specific, antibody 
was used at a 1:100 dilution and protein-A-g-galactosidase at 
a 1:50 dilution. Results are reported as A^jo P®'" embryo and 
were adjusted by subtraction of the embryos treated 
with the control antibody, N-S.8.1. A minimum of 20 embryos 
were used for each point and the standard error of the means 
are shown as error bars 
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Figure 24a. Expression of H-BK* antigens by BIO.BR preimplantation em­
bryos (o) and oocytes (•). Results are reported as Per 
outside cell and were calculated from the values shown 
Figure 23 and Table 7 
in 
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Figure 24b. Reactivity of B8-24-3 monoclonal antibody (anti-H-zb) on EL-4 
(H-2°) and RDM-4 (H-2*) cells. Cell ELISA. II was performed 
using B8-24-3 monoclonal antibody on EL-4 (o) or RDM-4 (•) 
cells. Rabbit anti-mouse, heavy and light chain specific, 
antibody was used at a 1:200 dilution and protein A-g-
galactosidase at a 1:400 dilution. Results are reported as 
^410 P®** and were adjusted by subtraction of the A^^o of 
wells treated with PBS. Each dilution was tested in du­
plicate and the standard deviations are shown as error bars 
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Figure 24c. Titration of B8-24-3 monoclonal antibody (anti-H-2K^) on 
C57BL/6 blastocyst stage embryos. Embryo ELISA II was per­
formed with either B8-24-3 (•) or N-S.8.1 (o) monoclonal 
antibodies. Rabbit anti-mouse IgG, heavy and light chain 
specific, was used at a 1:100 dilution and protein A-g-ga-
lactosidase. at a 1:50 dilution. Results are reported as 
per 5 embryos; each dilution was tested in duplicate and the 
standard deviations are shown as error bars 
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Figure 25. Reactivity of B8-24-3 (anti-H-Z^) monoclonal antibody on 
C57BL/6 (H-2°) (o) and BIO.BR (H-2k) (•) blastocyst stage 
embryos, using embryo ELISA II. Rabbit anti-mouse, heavy and 
light chain specific, antibody was used at a 1:100 dilution 
and protein-A-s-galactosidase at a 1:50 dilution. Results are 
reported as per 5 embryos; each dilution was tested in 
duplicate and the standard deviations are shown as error bars 
87 
0.08 n 
0.06-
O >» &_ 
.£3 J 
< 
0.04 
0.02 
0.00-1 1 1 ! r 
0 17 41 65 89 
Hours post-hCG 
Figure 26. Detection of H-EK^ antigen on preimplantation C57BL/6 preim-
plantation embryos (o) and oocytes (•) with the B8-24-3 mono­
clonal antibody (anti-H-2K") at a concentration of 0.1 mg/ml 
in embryo ELISA II. Rabbit anti-mouse, heavy and light chain 
specific, antibody was used at a 1:100 dilution and protein-A-
B-galactosidase at a 1:50 dilution. Results are reported as 
A410 per anbryo and were adjusted by subtraction of the A^^g 
of embryos treated with N-S.8.1. A minimum of 20 embryos were 
used for each point and the standard errors of the means are 
shown as error bars 
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Figure 27. Expression of H-2K*' antigens by C57BL/6 preimplantation em­
bryos (o) and oocytes (•). Results are reported as per 
outside cell and were calculated from the values shown in 
Figure 26 and Table 9 
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Table 7. Expression of H-2k antigens during development 
ELISA Results 
Time Mean cell No. of Mean A410 Per 
post-hCG No./Embryo "outside" "outside" 
(hrs) (S.E.)a blastomeres Embryo Cell cell 
17 (oocytes) 1.0(0.0) 1 0.043 0.043 0.043 
41 (2 cell) 2.0(0.0) 2 0.019 0.010 0.010 
65 (8 cell) 6.0(0.3) 6 0.016 0.003 0.003 
89 (blastocyst) 22.8(1.3) lib 0.070 0.003 0.006 
^Determined by the Tarkowski method (Tarkowski, 1966). A minimum of 
30 embryos were scored for each point. 
^Extrapolated from Handyside (1981). 
Q/TL region The expression of class I molecules encoded in the 
Qa-2 subregion by early embryos was determined using embryo ELISA II with 
both polyclonal antisera and monoclonal antibodies. In order to determine 
if embryos express Qa-2 antigens, CFl blastocysts were treated with dif­
ferent dilutions of D3.262, an IgM anti-Qa-2 monoclonal antibody; the N-
S.2.1 antibody was used as a negative control. The results in Figure 28a 
demonstrate that CFl blastocysts do express Qa-2 antigens and that a 1:50 
dilution is an appropriate dilution for the assay. In this experiment, 
rabbit anti-mouse antibody (n chain specific) was used at a 1:100 dilu­
tion, protein A-g-galactosidase a at 1:50 dilution and substrate at 4 
mg/ml. (The titration curve of rabbit anti-mouse, n chain specific, anti­
body was done at a later date, using protein A-g-galactosidase as shown in 
Figure 28b. This curve suggests that a 1:50 dilution of second antibody 
is optimal, but a 1:100 dilution is acceptable.) In the next experiment. 
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Figure 28a. Titration of D3.262 (anti-Qa-2^) monoclonal antibody (o) and 
N-S.2.1 (anti-sheep red blood cells) monoclonal antibody (•) 
on CFl blastocyst stage embryos. Embryo ELISA II was per­
formed using rabbit anti-mouse, y chain specific, antibody 
was used at a 1:100 dilution and protein-A-g-galactosidase at 
a 1:50 dilution. Results were collected in two experiments 
and are reported as P®*" ® embryos ; standard errors of 
the means are shown as error bars 
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Figure 28b. Titration of rabbit anti-mouse, ]x chain specific. Embryo 
ELISA II was performed using either the 03.262 monoclonal 
antibody or the N-S.8.1 monoclonal antibody at a 1:50 dilu­
tion. Protein A-g-galactosidase (Sigma) was used at a 1:100 
dilution. Results are reported as A^JQ per 5 CFl blasto­
cysts. Dilutions were tested in duplicate and the standard 
deviations are shown as error bars 
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Table 8. Experiments detecting H-EK^ antigens on C57BL/6 embryos® 
No. of Normalized 
embryos/ 
Experiment Stage Antibody Well Well Embryo Embryo 
oocyte B8-24-3 60 1.37 0.023 0.023 
61 1.48 0.024 0.024 
N-S.2.1 50 0.46 0.009 0.009 
53 0.23 0.004 0.004 
8 cell B8-24-3 10 0.60 0.060 0.060 
10 0.50 0.050 0.050 
N-S.2.1 10 0.40 0.040 0.040 
10 0.30 0.030 0.030 
Blastocyst B8-24-3 5 0.79 0.160 0.160 
5 0.43 0.086 0.086 
N-S.2.1 5 0.46 0.092 0.092 
5 0.23 0.046 0.046 
2 cell B8-24-3 30 1.87 0.062 0.038 
30 1.69 0.056 0.034 
27 1.01 0.037 0.022 
N-S.2.1 30 0.29 0.010 0.006 
30 0.19 0.006 0.004 
16 0.17 0.011 0.007 
Blastocyst B8-24-3 5 0.52 0.104 0.063 
6 0.50 0.083 0.051 
N-S.2.1 5 0.05 0.010 0.006 
6 0.02 0.003 0.002 
®Experiments were normalized to the blastocyst point in experiment 1 
by multiplying the values in experiment 2 by 0.63. 
blastocysts from six strains of mice were examined for Qa-2 antigen ex­
pression: CFl (outbred), C57BL/10J (Qa-2®), BIO.BR (Qa-2^). C57BL/6 (Qa-
^), B6.K2 (Qa-2®), B6.K1 (Qa-2*^). The results, shown in Figure 29 demon­
strate that embryos from strains possessing the Qa-2® allele express Qa-2 
antigens, whereas those from strains possessing the Qa-2^ allele do not 
express the antigen. The fact that the CFl embryos express comparable 
Figure 29. Reactivity of D3.262 (anti-Qa^) monoclonal antibody 
on blastocyst stage embryos. Embryo ELISA II was 
performed using rabbit anti-mouse IgM, p chain 
specific, at a 1:100 dilution and protein A-g-
galactosidase at a 1:50 dilution. Results are 
reported at A420 per 5 embryos and are adjusted by 
subtraction of A410 of embryos treated with the 
control antibody, N-S.2.1. A minimum of 20 embryos 
was used from each strain 
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Table 9. Expression of H-2b antigens during development 
ELISA Results 
Time 
post-hCG 
(hrs) 
Mean cell 
No./Embryo 
(S.E.)a 
No. of 
"outside" 
blastomeres 
Mean A410 Per 
Embryo Cell 
'outside" 
cell 
17 (oocytes) 1.0(0.0) 1 0.017 0.017 0.017 
41 (2 cell) 2.0(0.0) 2 0.025 0.025 0.013 
65 (8 cell) 8.0(0.3) 6 0.010 0.001 0.016 
89 (blastocyst) 29.6(1.3) 14b 0.053 0.018 0.037 
^Determined by the Tarkowski method (Tarkowski, 1966). A minimum of 
30 embryos were scored for each point. 
^Extrapolated from Handyside (1981). 
amounts of Qa-2 antigen as C57BL/10J embryos suggests that this is the 
predominant allele in this outbred population. These results were con­
firmed with the polyclonal anti-Qa-2 antiserum, B6.K1 anti-B6. The titra­
tion curve of this serum is shown in Figure 30. A dilution of 1:10 was 
used for Qa-2 antigen detection on blastocysts, as shown in Figure 31. 
The high reactivity of the BIO.BR embryos may be due to different back­
ground genes of the BIO.BR strain as compared to the B6.K1 strain. Thus, 
the polyclonal serum, which was made in B6.K1 mice, may have endogenous 
antibodies to BIO.BR antigens. 
To determine if early embryos express TL antigens, CFl blastocysts 
were treated with 18/20, an anti-TL antigen monoclonal antibody, in the 
embryo ELISA II. Results shown in Figure 32, demonstrate that early em­
bryos do not express TL antigens. The anti-TL monoclonal antibody was 
used at a 1:10 dilution, which is known (data not shown) to react with 
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Figure 30. Titration curve of anti-Qa-2 polyclonal serum on CFl (Qa-2 ; 
•) and BIO.BR {Qa-2";«) blastocyst stage embryos. Rabbit 
anti-mouse, heavy and light chain specific, antibody was used 
at a 1:100 dilution and protein-A-B-galactosidase at a 1:50 
dilution. Results are reported as P^r 5 embryos. Each 
dilution was tested in duplicate and standard deviations are 
shown as error bars. Open symbols represent the reactivity of 
CFl (D) and BIO.BR (o) embryos with normal mouse serum 
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Figure 31. Reactivity of anti-Qa-2 polyclonal serum on blastocyst 
stage ©nbryos. Polyclonal antiserum and normal mouse serum, 
diluted 1:10, were used in embryo ELISA II. Rabbit anti-
mouse, heavy and light chain specific, antibody was used at a 
1:100 dilution and protein-A-g-galactosidase at a 1:50 dilu­
tion. Results are expressed as per 5 embryos and are 
adjusted by subtraction of the A^jg of embryos treated with 
normal mouse serum. A minimum of 20 embryos was used from 
each strain and the standard deviations are shown as error 
bars 
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Figure 32. Expression of TL antigens by CFl embryos. CFl embryos were 
tested for expression of TL antigen with 18/20 monoclonal 
antibody» diluted 1:10, in embryo ELISA II. The anti-Qa-2 
polyclonal serum was used as a positive control. Rabbit anti-
mouse, heavy and light chain specific, antibody was used at a 
1:100 dilution and protein-A-e-galactosidase at a 1:50 dilu­
tion. Results are expressed as per 5 embryos and are 
adjusted by subtraction of A420 of embryos treated with the 
negative control. A minimum of 20 embryos was used for each 
point and the standard deviations are reported as error bars 
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Table 10. Experiments detecting Qa-2 antigens on CFl embryos^ 
No. of Normalized 
embryos/ A410/ A410/ 
Experiment Stage Antibody Well Well Embryo Embryo 
1 oocytes N-S.8.1 42 0.12 0.003 0.003 
42 0.13 0.003 0.003 
D3.262 42 0.61 0.015 0.015 
42 0.70 0.017 0.017 
2 cell N-S.8.1 35 0.44 0.012 0.012 
35 0.20 0.006 0.006 
D3.262 35 1.13 0.032 0.032 
35 1.10 0.031 0.031 
8 cell N-S.8.1 10 0.46 0.046 0.046 
10 0.26 0.026 0.026 
D3.262 10 0.98 0.098 0.098 
10 1.01 0.101 0.101 
2 oocytes N-S.8.1 42 0.04 0.001 0.003 
42 0.05 0.001 0.003 
D3.262 42 0.28 0.007 0.017 
blastocyst N-S.8.1 5 0.26 0.053 0.136 
5 0.32 0.063 0.161 
D3.262 5 1.32 0.264 0.676 
5 1.35 0.270 0.691 
3 oocytes N-S.8.1 40 0.08 0.002 0.006 
D3.262 40 0.24 0.006 0.017 
8 cell N-S.8.1 10 0.07 0.007 0.020 
10 0.07 0.007 0.021 
D3.262 10 0.31 0.031 0.089 
10 0.35 0.035 0.100 
• bl astocyst N-S.8.1 5 0.24 0.047 0.137 
5 0.16 0.033 0.096 
D3.262 5 1.34 0.267 0.776 
5 1.01 0.202 0.588 
^Experiments were normalized to the oocyte point in experiment 1 by 
multiplying the values of experiment 2 by 2.56 and experiment 3 by 2.91. 
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Table 11. Expression of Qa-2 antigens during development 
ELISA Results 
Time 
post-hCG 
(hrs) 
Mean cell 
No./Embryo 
( S.E . ) a  
No. of 
"outside" 
blastomeres 
Mean A410 Per 
Embryo Cel1 
"outside" 
cell 
17 (oocyte) 1.0(0.0) 1 0.011 0.011 0.011 
41 (2 cell) 2.0(0.0) 2 0.023 0.011 0.011 
65 (8 cell) 6.8(0.3) 6.8 0.069 0.010 0.010 
89 (blastocyst) 39.3(1.8) igb 0.550 0.014 0.029 
^Determined by the Tarkowski method (Tarkowski, 1966). A minimum of 
30 embryos were scored for each point. 
''Extrapolated from Handyside (1981). 
cells expressing TL antigens. 
The expression of Qa-2 antigen was tested at several stages of early 
mouse development (see Table 10). The results of these experiments show 
that Qa-2 antigens are detectable from the oocyte to the blastocyst stage 
of development (Figure 33). When the results were calculated on a per 
"outside" cell basis (see Table 11), it is seen that the amount of Qa-2 
antigen detected per "outside" cell doubles from the 8 cell stage to the 
blastocyst stage of development. These results are plotted in Figure 34. 
Class II antigen detection 
Class II expression by early embryos was examined using the YP-3 
monoclonal antibody and embryo ELISA II. The YP-3 titration curve is 
shown in Figure 35. From this experiment, it was decided to use the anti­
body at a 1:20 dilution. The rabbit anti-mouse IgG, heavy and light chain 
specific, antibody was used at a 1:100 dilution, the protein A-g-galacto-
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Figure 33. Expression of Qa-2® antigens by preimplantation embryos (o) 
and oocytes (•). Monoclonal antibody, D3.262, was used in 
embryo ELISA II. Rabbit anti-mouse, y chain specific, anti­
body was used at a 1:100 dilution and protein-A-g-galacto-
sidase at a 1:50 dilution. Results are expressed as per 
embryo and are adjusted by subtraction of the of embryos 
treated with the control antibody, N-S.2.1. A minimum of 20 
embryos was used for each time point and the standard errors 
of the means are shown 
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Figure 34. Expression of Qa-2 antigens by CFl prelmplantation embryos (o) 
and oocytes (•). Results are reported as per outside cell 
and were calculated from the values shown in Figure 33 and 
Table 11 
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Figure 35. Titration of YP-3 (anti-la) monoclonal antibody (o) and N-
3.8.1 (anti-sheep red blood cells) monoclonal antibody (•) on 
CFl blastocyst stage embryos. Embryo ELISA II was performed 
using rabbit anti-mouse, heavy and light chain specific, anti­
body was used at a 1:100 dilution and protein-A-g-galacto-
sidase at a 1:50 dilution. Results were collected in two 
experiments and are expressed as A^^o 5 embryos; standard 
errors of the means are shown as error bars 
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Table 12. Experiments detecting class II antigens on embryos* 
No. of Normalized 
Antibody 
embryos/ A410/ A410/ 
Experiment Stage Well Well Embryo Embryo 
1 2 cell N-S-2.1 35 0.20 0.006 0.003 
35 0.18 0.005 0.002 
YP-3 35 0.54 0.015 0.007 
8 cell N-S.2.1 20 0.15 0.008 0.003 
20 0.11 0.003 0.002 
YP-3 20 0.64 0.032 0.015 
blastocyst N-S.2.1 11 0.25 0.023 0.011 
11 0.30 0.027 0.012 
11 1.30 0.118 0.054 
11 1.30 0.118 0.054 
2 oocyte N-S.2.1 35 0.44 0.013 0.023 
35 0.10 0.003 0.006 
YP-3 35 0.88 0.025 0.047 
35 0.73 0.021 0.039 
blastocyst N-S.2.1 20 0.14 0.007 0.013 
20 0.20 0.010 0.019 
YP-3 20 0.67 0.033 0.061 
20 0.45 0.025 0.046 
3 oocyte N-S.2.1 28 1.10 0.039 0.039 
YP-3 26 1.47 0.056 0.056 
1 cell N-S.2.1 30 2.17 0.072 0.072 
27 1.40 0.052 0.052 
YP-3 30 1.68 0.056 0.056 
41 1.72 0.042 0.042 
2 cell N-S.2.1 20 0.30 0.015 0.015 
22 0.21 0.010 0.010 
YP-3 20 0.58 0.029 0.029 
21 0.36 0.017 0.017 
^Experiments were normalized to the blastocyst point in experiment 3 
by multiplying the values in experiments 1, 2, 4 and 5 by 0.46, 1.86, 0.17 
and 0.72, respectively. 
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Table 12. cont.& 
No. of Normalized 
embryos/ A410/ A410/ 
Experiment Stage Antibody Well Well Embryo Embryo 
2 cont. 8 cell N-S.2.1 10 0.09 0.009 0.009 
10 0.00 0.000 0.000 
YP-3 10 0.06 0.006 0.006 
10 0.04 0.004 0.004 
blastocyst N-S.2.1 6 0.13 0.022 0.022 
6 0.13 0.022 0.022 
6 0.09 0.015 0.015 
6 0.00 0.000 0.000 
3 blastocyst N-S.2.1 6 0.00 0,000 0.000 
YP-3 6 0.35 0.058 0.058 
6 0.20 0.033 0.033 
6 0.51 0.085 0.085 
6 0.19 0.032 0.032 
6 0.32 0.062 0.062 
4 blastocyst N-S.2.1 5 0.30 0.060 0.010 
5 0.19 0.038 0.006 
YP-3 5 0.84 0.168 0.029 
5 0.72 0.144 0.024 
5 8 cell N-S.2.1 15 0.15 0.010 0.007 
15 0.06 0.004 0.003 
YP-3 15 0.17 0.011 0.008 
15 0.22 0.015 0.015 
blastocyst N-S.2.1 5 0.28 0.056 0.040 
7 0.54 0.077 0.047 
YP-3 5 0.42 0.084 0.060 
5 0.46 0.066 0.047 
8Experiments were normalized to the blastocyst point in experiment 3 
by multiplying the values in experiments 1, 2, 4 and 5 by 0.46, 1.86, 
0.17 and 0.72, respectively. 
sidase at 1:50, and substrate at 4 mg/ml. 
The ontogeny of class II antigens on CFl embryos is shown in Figure 
36. The results, which were obtained in 5 experiments (Table 12), seem to 
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Figure 36. Detection of class II antigens on preimplantation mouse em­
bryos (o) and oocytes (•) with the YP-3 monoclonal antibody in 
embryo ELISA II. Rabbit anti-mouse, heavy and light chain 
specific, antibody was used at a 1:100 dilution and protein-A-
e-galactosidase at a 1:50 dilution. Results are reported as 
A410 P®** embryo and were adjusted by subtraction of the A^JQ 
of embryos treated with N-S.8.1. A minimum of 20 embryos was 
used for each point and the standard errors of the means are 
represented as error bars 
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Table 13. Expression of Class II antigens during development 
ELISA Results 
Time 
post-hCG 
(hrs) 
Mean cell 
No./Embryo ' 
(S.E.)a 
No. of 
"outside" 
blastomeres 
Mean A410 Per 
Embryo Cell 
•outside" 
cell 
17 (oocyte) 1.0(0.0) 1 0.021 0.021 0.021 
17 (1 cell) 1.0(0.0) 1 0.000 0.000 0.000 
41 (2 cell) 2.0(0.0) 2 0.011 0.006 0.006 
65 (8 cell) 6.8(0.3) 6.8 0.006 0.001 0.001 
89 (blastocyst) 39.3(1.8) 19b 0.037 0.001 0.002 
^Determined by the Tarkowski method (Tarkowski, 1966). A minimum of 
30 embryos were scored for each point. 
^Extrapolated from Handyside (1981). 
indicate a low level of expression of class II antigens on early mouse 
embryos. When the results are calculated on a per "outside" cell basis 
(Table 13 and Figure 37), it is seen that the amount of class II antigen 
appears to decrease from the oocyte to later stages of development. 
Expression of the Paternal Genome in Blastocyst Stage Embryos 
The expression of the paternal genome in blastocyst stage embryos was 
measured by determining H-2 antigen expression in embryos from the BIO.BR 
(H-2^) X C57BL/10J (H-2^) cross. Embryo ELISA II was used to determine 
whether blastocysts expressed the paternal antigens. Figure 38 and Table 
14b, which are a summary of the results from the 5 experiments shown in 
Table 14a, show the reactivity of the 11-4.1 (anti-H-2k) and B8-24-3 
(anti-H-2b) on embryos from BIO.BR, C57BL/10, (BlO.BRs X B10d')Fi (paternal 
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Figure 37. Expression of class II antigens by CFl preimplantation embryos 
(o) and oocytes («). Results are reported as per outside 
cell and were calculated from the values shown in Figure 36 
and Table 13 
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Figure 38. Reactivity of 11-4.1 (dark bars) and B8-24-3 (open bars) on 
blastocyst stage embryos from BIO.BR, C57BL/10 (BIO), (BlO.BRs 
X BlOd-jp^ (BlOer) and (BIO? x BlO.BRrfjFj (BlO.BRcc) strains. 
Results are reported as A^^o P®** ® embryos. A minimum of 10 
embryos was tested for each point; standard errors of the 
means are shown as error bars* 
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Table 14a. Experiments detecting paternal antigens on blastocyst stage 
embryos® 
No. ofNormalized 
embryos/ A410/ A410/ 
Experiment Strain Antibody Well Well Embryo Well 
1 C57BL/10 11-4.1 5 0.000 0.000 0.000 
B8-24-3 5 0.008 0.002 0.040 
2 C57BL/10 11-4.1 5 0.060 0.012 0.060 
B8-24-3 5 0.270 0.054 0.270 
BIO.BR 11-4.1 5 0.294 0.059 0.294 
B8-24-3 5 0.059 0.012 0.059 
BIO.BR 11-4.1 5 0.160 0.032 0.160 
5 0.157 0.031 0.157 
B8—24—3 5 0.120 0.024 0.120 
5 0.134 0.027 0.134 
BIO 11-4.1 5 0.233 0.047 0.233 
5 0.306 0.061 0.306 
B8-24-3 5 0.669 0.134 0.669 
3 BIO.BR 11-4.1 5 0.300 0.060 0.294 
38-24-3 5 0.130 0.026 0.127 
4 BIO.BR 11-4.1 5 0.650 0.130 0.342 
5 0.685 0.137 0.360 
5 0.244 0.049 0.128 
B8-24-3 5 0.304 0.061 0.160 
5 0.336 0.067 0.177 
5 0.410 0.082 0.216 
5 BIO.BR 11-4.1 5 0.600 0.120 0.270 
B8-24-3 5 0.000 0.000 0.000 
C57BL/10 11-4.1 5 0.000 0.000 0.000 
B8-24-3 5 0.520 0.104 0.274 
BIO 11-4.1 5 0.375 0.075 0.169 
5 0.440 0.088 0.198 
^Experiments were normalized to experiment 2 by multiplication of 
the values in experiment 1, 3, 4 and 5 by 1.68, .98, .526, and .45, 
respectively. 
m 
Table 14b. Summary of experiments detecting paternal 
on blastocyst stage embryos 
antigen expression 
Paternal 
Strain Antigen Anti body 
A410 
Well 
+ S.E.M. 
BIO.BR H-2k 11-4.1 0.281+.038 
B8-24-3 0.123+.029 
C57BL/10 H-2b 11-4.1 0.025+.013 
B8-24-3 0.284+.055 
(BIOS X B10.BRf)Fi H-Z^ 11-4.1 0.159+.001 
B8-24-3 0.127+.007 
(B10.BR5 X B10d')Fi H-2b 11-4.1 0.236+.030 
B8-24-3 0.555+.110 
antigen: H-2b) and (BlOs X B10.BRf)Fi (paternal antigen: H-2k). The 
results demonstrate that the paternal antigen is expressed in blastocyst 
stage embryos. It is not possible to compare the amount of maternal 
antigen versus paternal antigen due to the crossreactivity of the B8-24-3 
monoclonal antibody. 
Synthesis of H-2 Antigens by Early Embryos 
To determine whether H-2 antigens, detectable on mouse embryos, are 
synthesized by the embryos themselves or are merely cytophilically bound 
to the embryonic cell surface, blastocyst stage embryos were stripped of 
their antigens and allowed time to resynthesize the cell surface mole­
cules. Two enzymes, pronase and papain, were used to remove the antigens 
from the embryo cell surface. Papain acts specifically on proteins with 
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globular domains such as H-2 or immunoglobulins (Nathenson and Davies, 
1966; Porter, 1973). Pronase is a general protease which will act on all 
proteins regardless of conformation. After enzyme treatment, the embryos 
were allowed to recover and the regeneration of H-2 antigens was detected 
by embryo ELISA I. 
Pronase treatment 
For the pronase recovery experiments, the time of incubation with 
the enzyme was determined from the experiment shown in Figure 39. It was 
found that the complete removal of surface antigens reacting in the ELISA 
method is obtained 10 minutes after enzyme treatment. However, 6 minutes 
was used as the time of pronase treatment for the recovery experiments 
because longer treatments resulted in embryonic death. 
In Figure 40, P815 cells (Figure 40A) or embryos (Figure 40B) were 
treated with pronase for 6 minutes and immediately assayed for cell sur­
face antigen expression with anti-H-2 Ml/42 monoclonal antibody (light 
bars) or rabbit anti-mouse polyclonal antibody (open bars). The graph 
shows that pronase removed both H-2 and other cell surface antigens. A 3 
hour recovery period brought the absorbance back to its original level as 
detected by the Ml/42 monoclonal antibody (dark bars). A comparison of 
Figures 40A and 40B shows that the embryos were much more susceptible to 
pronase than were the tumor cells. The enzyme removed nearly all surface 
antigens detectable by both types of antibodies (Ml/42 and rabbit anti-
mouse polyclonal). Furthermore, no additional recovery was shown by the 
embryos after a 3 hour incubation period. A longer incubation period (6 
hours) did not change the results. 
Papain 
Papain treatment of cells and embryos was done for 30 minutes as this 
was the optimum time reported for the removal of H-2 antigens from P815 
cells (Gromkowski et al., 1983). Figure 41A shows that papain removes 
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Figure 39. Time course of treatment of mouse blastocysts with pronase. 
After pronase treatment the embryos were assayed by the ELISA 
method with either monoclonal antibody, Ml/42 (•) or PBS 
(o) 
Figure 40. Treatment of cells (A) or embryos (B) with pronase. 
The cells or embryos were either subjected to the 
ELISA procedure innnediately after pronase treatment, 
using monoclonal antibody Ml/42 (light bar) or 
polyclonal rabbit anti-mouse antibody (open bar), or 
after a 3 hour recovery period (dark bar) after 
which they were assayed with Ml/42 monoclonal 
anti body 
115 
B 
Cells Embryos 
Figure 41. Treatment of cells (A) or embryos (B) with papain. 
The cells or embryos were either subjected to the 
ELISA procedure immediately after pronase treatment, 
using monoclonal antibody Ml/42 (light bar) or 
polyclonal rabbit anti-mouse antibody (open bar), or 
after a 3 hour recovery period (dark bar) after 
which they were assayed with Ml/42 monoclonal 
antibody 
117 
Cells Embryos 
118 
most of the H-2 antigens from the P815 cell surface since more than an 80% 
decrease in absorbance was observed with the Ml/42 antibody. The decrease 
in absorbance with the polyclonal anti-mouse serum was lower, showing the 
presence of non-H-2 murine antigens after papain treatment. After a 3 
hour recovery period, more than 95% of the original level of absorbance 
was detected as a result of the resynthesis of H-2 antigens by the cells. 
Treatment of the embryos with papain showed very similar results 
(Figure 41B). As with the cells, a sharp decrease in absorbance was seen 
when the Ml/42 monoclonal antibody was used, but less of a decrease was 
seen when the polyclonal serum was used. This shows that anbryos express 
both H-2 and non-H-2 antigens. The embryos recovered 60% of the original 
antigen level after a 3 hour incubation. The 60% recovery ivas not im­
proved upon by a longer incubation period (6 hours). 
Analysis of the Fed Gene 
Mapping of the Fed gene within the 1^2 complex 
By examining the rates of development of embryos of a series of con-
genic mouse strains, Goldbard et al. (1982) were able to show that the Fed 
gene is associated with the H-2 complex. To further map the location of 
the Fed gene, the numbers of cells per embryo at the blastocyst stage of 
development of three congenic recombinant strains of mice were determined. 
Table 15 shows the genetic makeup and the number of cells per embryo of 
the three strains, BIO.AM, B10.A(4R) and B10,A(5R), as well as the proto­
type strains, BIO.BR (slow developing strain) and C57BL/10Sn (fast devel­
oping strain). The BIO.AM strain contains the k allele, a slow Fed 
allele, in all H-2 subregions except the D subregion which has a b allele, 
a fast Fed allele. BIO.AM embryos are fast developing embryos (see Table 
15), and therefore, the Fed fast allele maps to the 'D-end' of the H-2 
complex. This conclusion is supported by the B10.A(4R) and B10.A(5R) 
119 
Table 15. Mapping the Ped gene to the D end of the H-2 complex^ 
Mean 
No. Cell 
Mouse H-2 Complex Embryos No./Embryo 
Strain K Ag h Ea S 0 Scored (S.E.M.) 
C57BL/10Sn b b b b b b b 48 33.1(2.1) 
BIO.BR k k k k k k k 50 22.8(1.3)b 
B10.A(4R) k k k k b b b 35 30.7(1.9) 
B10.A(5R) b b b b k d d 36 31.1(1.5) 
BIO.AM k k k k k k b 34 29.6(1.7) 
3Embryos were collected at 89 hours post-hCG and the mean cell 
number per embyro determined by the method of Tarkowski (1966). 
•^Significantly lower than C57BL/10Sn at P<0.01. 
results. 
Recently, more information has become known about the distal portion 
of the H-2 complex, especially the Q/TL region. It Is known that the 
crossover events that gave rise to the congenic and recombinant mice used 
in this study occurred telometric to the D subregion (Klein et al., 1982). 
Thus, it became important to examine the major histocompatibility complex 
class I phenotype of all the congenic mouse strains analyzed for Ped gene 
expression. As shown in Table 16, the only apparent consistency is that 
the two slow developing strains, BIO.BR and 610.RIII, express the Oa-2b 
allele, whereas the fast developing strains express the Qa-2^ allele. In 
order to determine if the Ped gene maps to the Oa-2 subregion, two con­
genic mouse strains, B6.K1 and B6.K2, which differ only in the Oa-2 subre­
gion were examined. The genetic makeup and the number of cells per embryo 
at the blastocyst stage of these strains is shown in Table 17. Also shown 
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Table 16. Class I molecules of congenic mouse strains 
Strains K 0 qa-2 Tla qa-1 Fed Phenotype 
C57BL/10Sn b b a b b fast 
BIO.02 d d a c b fast 
BIO.BR k k b a a slow 
BIO.RIII r r b b b slow 
BIO.S s s a b b fast 
BIO.Q q q a b b fast 
BIO.PL p p a a a fast 
B10.A(4R) k b a b b fast 
B10.A(5R) b d a a a fast 
BIO.AM k b a b b fast 
Table 17. Mapping of the fed gene to the Qa-2 Region* 
Mouse Class I Molecules No. Embryos No. Cells/Embryo 
Strain K D Qa-2 Tla Qa-1 Scored Expt. (S.E.M.) 
B6.K1 b b b b b 33 2 20.4(1.11)^ 
B6.K2 b b a b b 78 3 31.0(1.41) 
C57BL/6 b b a b b 56 3 29.6(1.66) 
*Embryos were collected at 89 hours post-hCG and the mean cell number 
per embryo determined by the method of Tarkowski. 
^Significantly lower than congenic strain B6.K2 at P<0.005. 
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are data for the background strain, C57BL/6J. The results show that the 
B6.K1 embryos have significantly fewer cells than B6.K2 embryos and there­
fore, the B6.K1 strain is a slow developing strain. Because B6.K1 (Qa-2b) 
and B6.K2 (Qa-2^) differ from each other only in the Oa-2 subregion (see 
Table 17) the Ped gene appears to map to the Qa-2 subregion of the H-2 
complex. 
Classical segregation analysis of the Ped gene 
To provide proof that two genes are linked, segregation studies in F2 
or backcross generations must be done. In this study, a backcross gener­
ation was produced as described in Figure 2 (see Materials and Methods) 
and examined to determine if the Ped gene is linked to the H-2 complex. 
The embryos were collected in Whitten and Biggers' medium at 93 hours 
post-hCG, divided into morulae and blastocysts, and treated with either 
anti-H-2k (11-4.1, 0.1 mg/ml) or anti-H-2b (B8-24-3, 0.1 mg/ml) monoclonal 
antibody in embryo ELISA II, described above. Figure 42 shows the reactiv­
ity of 11-4.1 on the backcross embryos as well as on embryos from the 
parental strains, BIO.BR and C57BL/10 (BIO).. The BIO.BR and backcross 
embryos show a positive response, while the BIO embryos do not. When the 
embryos were treated with B8-24-3 (Figure 43), only the BIO and backcross 
blastocyst stage embryos show a positive response. The data for Figures 
42 and 43 were compiled from the experiments in Tables 18 and 19a, respec­
tively. This data is suimnarized in Table 19b. Thus, the fast developing 
embryos (blastocysts) of the backcross generation are of the bk haplotype 
and the slow developing embryos (morulae) are of the kk haplotype. These 
results confirm that the Ped gene is linked to the H^i complex. 
In the next experiment, the blastocyst stage embryos from the back-
cross were transferred to pseudopregnant foster females. The resulting 
offspring were H-2 typed as described above. The observed H-2 types of 
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Table 18. Segregation analysis of the Fed gene: 
embryos with 11-4.1® 
H-2 typing of backcross 
Experiment Strain 
No. of 
embryos/ 
Well 
A410/ 
Well Embryo 
Normalized 
1 BIO.BR 5 0.294 0.059 0.059 
C57BL/10 5 0.060 0.012 0.012 
2 BIO.BR 5 0.120 0.024 0.059 
C57BL/10 5 0.000 0.000 0.000 
3 BIO.BR 7 0.310 0.044 0.059 
C57BL/10 6 0.040 0.007 0.009 
Blastocyst 5 
5 
0.090 
0.060 
0.018 
0.012 
0.024 
0.016 
Morula 5 
3 
0.420 
0.030 
0.084 
0.010 
0.112 
0.013 
4 BIO.BR 6 
5 
4 
0.462 
0.380 
0.096 
0.077 
0.076 
0.024 
0.077 
0.076 
0.024 
C57BL/10 5 0.110 0.022 0.022 
Blastocyst 6 
6 
5 
0.740 
0.670 
0.250 
0.123 
0.112 
0.050 
0.123 
0.112 
0.050 
^Experiments were normalized to the C57BL/10 point in experiment 4 
by multiplying experiment 1 by 1.0, experiment 2 by 2.46 and experiment 3 
by 1.34 as described in Materials and Methods. 
Figure 42. Segregation analysis for the Fed gene linkage study. 
H-2 typing of embryos was done using the 11-4.1 
(anti-H-2K) monoclonal antibody and embryo ELISA II. 
Results are reported as A410 per 5 embryos. A 
minimum of 20 embryos was used for each point. The 
light bar represents BIO.BR control embryos, the 
dark bar C57BL/10 (BIO) control embryos and the open 
bars represent experimental embryos divided into 
blastocysts and morulae 
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Table 19a. Segregation analysis of the Fed gene: H-2 typing of backcross 
embryos with 68-24-3* 
No. of Normalized 
embryos/ A4IO/ A410/ 
Experiment Strain Well Well Embryo Well 
1 BIO.BR 5 0.060 0.012 0.060 
C57BL/10 5 0.270 0.054 0.054 
2 BIO.BR 5 0.000 0.000 0.000 
C57BL/10 5 0.106 0.021 0.052 
3 BIO.BR 6 0.240 0.040 0.040 
5 0.095 0.019 0.019 
4 0.220 0.055 0.055 
C57BL/10 5 0.360 0.072 0.072 
B1astocyst 6 1.260 0.210 0.210 
7 1.036 0.148 0.148 
Morula 5 0.260 0.052 0.052 
5 0.090 0.018 0.018 
5 0.000 0.000 0.000 
^Experiments were normalized to the C57BL/10 point in experiment 3 
by multiplying experiment 1 by 1 and experiment 2 by 2.46. 
the offspring were compared to the expected H-2 types in a chi-square 
analysis as shown in Table 20. The results show that there is a signifi­
cant difference between the observed and expected values (P £0.01). This 
supports the conclusion obtained in the embryo ELISA experiments, namely 
that the Fed gene is linked to the H-2 complex. 
Figure 43. Segregation analysis for the Ped gene linkage study. 
H-2 typing of embryos was done using the B8-24-3 
(anti-H-2D) monoclonal antibody and embryo ELISA II. 
Results are reported as A410 Per 5 embryos. A 
minimum of 20 embryos was used for each point. The 
light bar represents BIO.BR control embryos, the 
dark bar C57BL/10 (BIO) control embryos and the open 
bars represent experimental embryos divided into 
blastocysts and morulae 
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Table 19b. Summary of H-2 antigen expression by backcross embryos* 
Strain 11-4.1 (anti-H-2'^) B8-24-3 (anti-H-2'') 
BIO.BR 0.047 + 0.0096 0.025 + 0.0088 
C57BL/10 0.011 + 0.0039 0.059 + 0.0051 
Blastocyst 0.065 + 0.0199 0.179 + 0.0290 
Morula 0.071 + 0.0210 0.023 + 0.0120 
^Results are expressed as A^im per embryo and were calculated from 
the normalized results in Tables lo and 19. 
Inhibition of Development by Anti-Qa-2 Monoclonal Antibodies 
Previous experiments have shown that embryos expressing the fast Ped 
allele also express Qa-2 antigens; embryos expressing the slow Ped allele 
show an absence of Qa-2 antigens (see Figures 29 and 31). Therefore, the 
presence of Qa-2 antigens seems to affect the rate of development. In 
order to further test the role of Qa-2 antigens in development, fast de­
veloping, Qa-2*, embryos were incubated overnight with purified anti-Qa-2 
monoclonal antibody to bind the antigens. The effect of the antibody on 
embryonic development was measured by their ability to incorporate 
thymidine after the incubation period as described in the Materials and 
Methods. The results, which were collected in three experiments (Table 
21a), are summarized in Table 21b and shown graphically in Figure 44. The 
presence of antisera enhances the incoporation of ^H-thymidine by the 
embryos, as can be seen by comparing the cpm of the control embryos to the 
cpm of the embryos treated with high dilutions of either antibody. Low 
129 
Table 20. Chi Square Analysis of Backcross Embryos 
Hypothesis: The Fed gene is not linked to the H-2 complex. Therefore, 
fast developing embryos (blastocysts) have a 502 chance of being of 
the bk haplotype and a 50% chance of being of the kk haplotype. 
Results: 
bk 
Observed 
10 
Expected 
7.5 
kk 3 7.5 
The observed and expected values are significantly different (P£ 
0.05). 
Conclusion: The Fed gene is linked to the H-2 complex. 
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Table 21a. Experiments measuring the effect of the D3.262 (anti-Qa-2) 
monoclonal antibody on development 
Experiment Antibody 
RÔI 
Dilution Embryo cpm cpm/embryo 
Brinster's 
N-S.8.1 1:20 
1:100 
10 
10 
10 
10 
10 
10 
4310 
3030 
1653 
2079 
5790 
4661 
431 
303 
165 
208 
579 
466 
03.262 1:20 
1:100 
Brinster's 
N-S.8.1 
03.262 
03.262 
10 
20 
50 
100 
200 
500 
20 
50 
100 
500 
10 
10 
10 
10 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
8 
1735 
2309 
2693 
2410 
5239 
6709 
3053 
2013 
2409 
1858 
3234 
4317 
7805 
5420 
6977 
5953 
9798 
12160 
1100 
1194 
1650 
1980 
3283 
7580 
6661 
174 
231 
269 
241 
524 
671 
382 
252 
301 
232 
404 
540 
976 
678 
872 
744 
1225 
1520 
138 
149 
206 
248 
410 
948 
833 
Table 21a. cont. 
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No. 
Experiment Antibody Dilution Embryos cpm cpm/embryo 
Brinster's 10 681 68 
10 1459 146 
N-S.8.1 1:50 10 828 83 
1:100 10 1009 101 
D3.262 1:50 10 783 78 
10 626 63 
1:100 10 649 65 
10 1550 116 
Table 21b. Summary of inhibition of development by D3.262 
Antibody Dilution 
cpm+(S.E.M.)/ 
embryo 
Brinster's 599+56 
N-S.2.1 1:10 317+46 
1:20 285+20 
1:50 487+34 
1:100 794+64 
1:200 808+45 
1:500 1372+104 
D3.262 1:20 236+49 
1:50 307+42 
1:100 453+43 
1:500 890+410 
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Figure 44. Effect of D3.262 monoclonal antibody on development. D3.262 
(anti-Qa-2®) monoclonal antibody (a) or N-S.2.1 (anti-sheep 
red blood cells) monoclonal antibody (•) were diluted in 
Brinster's medium and incubated with CFl embryos in the DNA 
synthesis assay. Results were collected in 3 experiments. A 
minimum of 20 embryos was used for each point and standard 
errors of the means are shown- as error bars. 
(•) - embryos treated with Brinster's alone 
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dilutions of antibody show an inhibitory effect on the ^ H-thymidine in­
corporation. The incorporation of %-thyinidine by embryos treated with 
03.262 monoclonal antibody, is less than that of embryos treated with the 
control antibody, N-S.2.1, at all dilutions. These results suggest that 
blockage of Qa-2 antigens by antibodies, may effect development. 
H-2 Antigen Purification 
H-2Kk antigen isolation 
H-2Kk antigens were isolated from RDM-4 cells by affinity chromatog­
raphy. Whole cell lysates were prepared from 10^ RDM-4 cells, which had 
been radiolabeled with 5 mCi of and from 5.8 x 10^ unlabeled cells 
by detergent solubilization as described in the Materials and Methods. 
The lysates were combined and mixed with Sepharose 4B overnight in order 
to remove any materials with an affinity for Sepharose. 
An affinity column of 11-4.1 monoclonal antibody, was prepared 
as described in Materials and Methods. The column was loaded and eluted 
and the column profile is shown in Figure 45. Peak fractions, 90-125, 
were pooled (pool SI) and dialyzed against storage buffer. A total of 36 
ml were collected and stored at -20^0. 
The 11-4.1 affinity column was again equilibrated with Triton-Tris 
buffer and the unbound lysate was run over the column again. Following 
the procedure described above, the gel was washed and bound material was 
eluted (see Figure 46). Peak fractions were pooled (pool S2), dialyzed 
against storage buffer, and stored at -200C. 
Protein concentration of the two pools was measured by the method of 
Lowry et al. (1951). Analysis showed that SI contained 40.5 ng/ml and S2 
contained 43.3 ng/ml of protein. A 12% SDS-polyacrylami de gel of the 
samples shows bands at 45,000 and 12,000 molecular weight, as well as 
several high molecular weight bands (Figure 47). The 45,000 dalton band 
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Figure 45. Elution profile of antigens from the 11-4.1 
affinity column. (First run resulting in pool SI.) 
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Figure 46. Elution profile of antigens form the 11-4.1 affinity 
column. (First run resulting in pool S2.) 
Figure 47. SDS-PA6E of H-2Kk antigens. High molecular weight 
standards are shown in Lane 4; low molecular weight 
standards in Lane 5. Lane 1 contains 5 wg of S2 and 
Lane 6 contains 5 pg of SI. Molecular weights in 
daltons are indicated 
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represents the heavy chain of the H-2 antigen and the 12,000 molecular 
weight band is B2 microglobulin. The high molecular weight products are 
most likely unreduced and differently glycosylated antigens. The auto-
radiograph of the gel is shown in Figure 48. Major bands can be seen in 
Figure 48 at 45,000 and 12,000; other higher molecular weight bands can 
also be seen which represent the unreduced antigen. These results indi­
cate that the sample contains H-2 antigen that is partially pure. The SI 
and S2 pools were combined and used in further experiments. 
Blocking Experiments 
It is possible that the antibodies used to detect antigens on the 
surface of the embryos may be crossreacting with viral antigens, differ­
entiation antigens, or other antigens outside the H-2 complex. In order 
to prove that the antibodies are detecting H-2 antigens, it is necessary 
to do blocking studies with purified antigens. The effect of pure H-2k 
antigens on the binding of the 11-4.1 (anti-H-2k) to RDM-4 (H-2k) cells 
and to BIO.BR (H-2k) embryos was measured. 
Inhibition of 11-4.1 binding to RDM-4 cells 
The effect of pure antigen on 11-4.1 monoclonal antibody binding to 
RDM-4 cells was measured with cell ELISA II. RDM-4 cells were fixed to 
the wells of a 96 well plate and cell ELISA II was performed in the pres­
ence of increasing amounts of H-2k antigen. Figure 49 shows the effect of 
the antigen on 11-4.1 and B8-24-3 monoclonal antibody binding to RDM-4 
cells. As the amount of pure antigen increases, the A410 or binding of 
the 11-4.1 to the cells decreases. There is little effect, if any on B8-
24-3 binding. 
The effect of the pure antigen on the binding of 88-24-3 (anti-H-2^) 
to EL-4 (H-2^) cells is shown in Figure 50 and Table 22. The results of 
this experiment show that at the highest concentration tested, which is a 
Figure 48. Autoradiograph of SDS-PAGE shown in Figure 47. 
Molecular weights in daltons are indicated 
Ldnss. - J 
45,000 
14,000 
141 
0.8-1 
0.6-
ug of H—2 antigen/Well 
Figure 49. Effect of H-2^ antigens on binding of 11-4.1 to RDM-4 
cells. Cell ELISA II was performed using rabbit anti-mouse, 
heavy and light chain specific, antibody was used at a 1:200 
dilution and protein A-&-galactosidase at a 1:400 dilution. 
Results are reported as versus yg of H-Z^ antigen per 
well. 11-4.1 (o) and B8-24-3 (o) monoclonal antibodies were 
used at a 1:200 dilution. (a)-PBS 
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Figure 50. Effect of antigens of the binding of 11-4.1 and B8-24-3 
monoclonal antibodies to (A) RDM-4 cells and (B) EL-4 cells. 
Cell ELISA II was performed. H-2K* antigen was added at a 
concentration of 92.4 wg/well and the monoclonal antibodies 
were used at a 1:200 dilution. Results are reported as 
per well. Open bars represent results in the absence of anti­
gen; closed bars are results when the antigen was present. 
Each point was tested in duplicate and the standard deviations 
are shown as error bars 
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Table 22. The effect of purified H-2Kk antigen on the binding of 
monoclonal antibodies to tumor cell lines 
A410 
Cell Antigen Well ^410 
Line Antibody (ng/well) (S.E.M.) Reduction 
RDM-4 11-4.1 0 0.407+0.045 
92.5 0.187+0.064 54 
B8-24-3 0 0.093+0.010 
92.5 0.072+0.017 22 
EL-4 11-4.1 0 0.049+0.002 
92.5 0.036+0.000 26 
B8-24-3 0 0.315+0.004 
92.5 0.275+0.002 13 
molar excess of 1000 antigen molecules to antibody molecules, there is a 
54% reduction in 11-4.1 antibody binding to RDM-4 cells. The necessity 
for the high excess of antigen probably reflects the presence of denatured 
antigens in the sample. The antigen has a slight affect on the binding of 
the B8-24-3 antibody to EL-4 cells. 
Inhibition of 11-4.1 binding to BIO.BR embryos 
Embryo ELISA II was used to measure the effect of pure H-2Kk antigen 
on 11-4.1 binding to BIO.BR embryos. Blastocyst stage embryos were placed 
in 50 nl of PBS containing 92.5 ng of pure H-2Kk antigen to which 50 nl of 
a 0.1 mg/ml solution of either 11-4.1 of B8-24-3 monoclonal antibody was 
added. Following a two hour incubation, embryo ELISA II was performed. 
The results in Figure 51, which were calculated from the experiments shown 
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Table 23. Experiments determining the effect of purified H-2Kk antigen on 
monoclonal antibody binding to embryos® 
Expt. Strain Antibody 
Antigen 
(ug/well) 
No. 
Embryos 
A410/ 
Well 
Normalized 
1 BIO.BR 11-4.1 0 5 0.100 0.830 
0 5 0.100 0.830 
0 5 0.060 0.493 
92.5 5 0.080 0.664 
92.5 5 0.040 0.332 
92.5 5 0.020 0.166 
B8-24-3 0 5 0.000 0.000 
0 5 0.000 0.000 
0 5 0.000 0.000 
2 BIO.BR 11-4.1 0 5 0.590 0.720 
92.5 5 0.010 0.012 
3 BIO.BR 11-4.1 0 5 0.600 0.600 
0 5 0.840 0.840 
92.5 5 0.130 0.130 
92.5 5 0.090 0.090 
B8-24-3 0 5 0.030 0.030 
0 5 0.040 0.040 
92.5 5 0.020 0.020 
92.5 5 0.030 0.030 
C57BL/6 11-4.1 0 5 0.050 0.050 
0 5 0.010 0.010 
92.5 5 0.040 0.040 
92.5 5 0.020 0.020 
B8-24-3 0 5 0.770 0.770 
0 5 0.690 0.690 
92.5 5 0.430 0.430 
92.5 5 0.550 0.550 
^Experiments were normalized to the BIO.BR point (without antigen) 
in experiment 3 by multiplying the values in experiment 1 by 8.3 and 
experiments 2 by 1.22. 
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Figure 51. Effect of antigens on the binding of 11-4.1 and B8-24-3 
monoclonal antibodies to (A) BIO.BR and (B) C57BL/6 blastocyst 
stage embryos. The antibodies were used at a concentration of 
0.1 mg/ml in the embryo ELISA II. Rabbit anti-mouse, heavy 
and light chain specific, antibody was used at a 1:100 dilu­
tion and protein-A-g-galactosidase at a 1:50 dilution. Re­
sults are reported as A^^o P®** 5 embryos; a minimum of 10 
embryos was used for each test and the standard errors of the 
means are shown as error bars. Open bars represent the re­
sults in the absence of antigen; closed bars are results when 
92.5 ug of H-ZK* were present 
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in Table 23, show that the H-2Kk antigen inhibits the binding of the 11-
4.1 antibody to BIO.BR embryos. The antigen reduced the amount of 11-4.1 
binding to BIO.BR embryos 68%, while only inhibiting the binding of 88-24-
3 to C57BL/6 embryos 332 (see Table 24). The effect of the pure H-2Kk 
antigen on B8-24-3 antibody confirms the crossreactivity of this antibody 
with embryos of the H-2k haplotype. 
Table 24. The effect of purified H-2Kk antigen on the binding of monoclonal 
antibodies to blastocyst stage embryos 
A410 
Anti gen Wei 1 ^410 
Strain Antibody (ug/well) (S.E.M.) Reduction 
BIO.BR 11-4.1 0 0.720+0.053 
92.5 0.232+0.088 68 
B8-24-3 0 0.035+0.005 
92.5 0.025+0.005 29 
C57BL/6 11-4.1 0 0.030+0.020 
92.5 0.030+0.010 0 
B8-24-3 0 0.730+0.040 
92.5 0.490+0.060 33 
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DISCUSSION 
In this work, we describe the development of an assay that allows the 
detection of antigens on the surface of preimplantation embryos. Using 
this assay, we have followed the ontogeny of H-2 and Qa-2 antigens during 
development. In addition, we have shown that the H-2 associated gene. 
Fed, is linked to the H-2 complex and maps to the Qa-2 subregion of the 
complex. 
Embryo ELISA 
The ELISA method is often the method of choice for the detection of 
cell surface antigens (Glynn and Ison, 1981). It has been used in studies 
of viruses, bacteria, somatic mammalian cells, fungi etc. The application 
of the ELISA procedure to the study of the embryo cell surface had not 
been reported at the commencement of this work. The conditions used for 
the ELISA methods described in this dissertation are summarized in Table 
25. The method is extremely sensitive. The amplified ELISA is at least 
10 times more sensitive than the embryo cytotoxicity assay (compare Fig­
ures 16 and 17). It is also possible to detect antigens on embryos with­
out amplification, but the use of a second antibody gives six times more 
sensitivity (Figure 19). The embryo ELISA is versatile. In this study, a 
number of different types of monoclonal antibodies were used, including an 
IgM (D3.262), an IgGj (B8-24-3), an IgG2a (11-4.1) and two rat monoclonal 
antibodies, Ml/42 and 53-7. The assay is not dependent on complement, and 
therefore, does not require a cytotoxic antibody. This is a great advan­
tage because many monoclonal antibodies are not cytotoxic and because com­
plement is a source of variability and nonspecific cytotoxicity. The 
assay can be used with zonea intact embryos (Figure 15). This is impor­
tant because embryos that have had their zonea removed, are more fragile 
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Table 25. Suiranary of ELISA conditions used In these studies. 
Second Protein A Substrate 
ELISA Antibody g-galactosidase Concentration 
Cell ELISA I Rabbit anti-
rat, 1:200. 
1:400 4mg/ml 
Cell ELISA II Rabbit anti-
mouse, either 
heavy and light 
chain specific, 
1:200, or Heavy 
chain specific, 
1:200. 
1:400 4mg/ml 
Embryo ELISA I Rabbit anti-
rat, 1:100. 
1:50 4mg/ml 
Embryo ELISA II Rabbit anti-
mouse, either 
heavy and light 
chain specific, 
1:100, or Heavy 
chain specific, 
1:100. 
1:50 4mg/ml 
and difficult to work with. Cells are often lost from the embryo during 
assays which require zonea removal. The assay itself is technically sim­
ple, but does require some expertise in working with embryos. Investi­
gators not familiar with embryo manipulation have reported difficulties in 
obtaining results. These difficulties were overcome with practice. 
The embryo ELISA does have some disadvantages. A large degree of 
variability is seen between individual experiments. Biological variation 
among individual embryos and operator differences contribute to the ex­
perimental variability. Experimental reproducibility may also vary with 
the primary antibody used. For this reason, it is necessary to repeat 
experiments. Many of the experiments shown here were done several times 
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(see Tables 6a, 8, 10, 12, 14a, 18, 19a and 22). In these instances, the 
results were normalized to a common point in all the experiments as de­
scribed in Materials and Methods. Repetition was also needed because of 
the difficulty experienced in obtaining sufficient numbers of embryos. 
Another disadvantage of the embryo ELISA is the lack of automation. Auto­
mation would increase the number of tests that could be done in a single 
experiment. It would also reduce some of the experimental variability. 
One disturbing feature of the embryo ELISA data are the apparent 
decrease in the A410 for blastocyst stage embryos with time. This is 
best seen in Table 6a. (The experiments are shown in chronological 
order.) The efficiency of the protein A-g-galactosidase was suspected, 
and the compound was purchased from a second supplier, Sigma. When the 
enzyme purchased from Sigma was compared with that purchased from Zymed 
(data not shown), the Sigma protein A-g-galactosidase was found to be much 
more active. The Sigma protein A-g-galactosidase is stored in glycerol 
and thus, should be more stable than enzyme stored in a buffer lacking 
glycerol (enzyme purchased from Zymed is not stored in glycerol). Inves­
tigators should be aware of the problems that can occur with some rea­
gents. 
The ELISA method presented in this dissertation is sensitive, but it 
is possible that the sensitivity could be increased. One goal would be to 
be able to assay individual embryos. Suitable dilutions of the second 
antibody have been chosen (see Table 25), but the sensitivity of the assay 
might increase with lower dilutions. Recent experiments have also shown 
that dilution of the primary antibody in buffer containing 10% fetal calf 
serum, rather than in buffer alone, increases the absorbance values. 
Finally, the concentration or nature of the enzyme and substrate could be 
changed. For instance, the use of a fluorescent substrate for g-galacto-
sidase might increase the sensitivity of the assay. 
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We believe that in spite of the disadvantages discussed above, the 
versatility and sensitivity, along with the potential for greater sensi­
tivity, will make the embryo ELISA method the method of choice for future 
studies of the embryonic cell surface. 
Detection of MHC Antigens on Embryos 
A summary of the expression of MHC antigens by blastocyst stage em­
bryos is shown in Table 26. The ontogeny of H-2 antigens on embryos and 
oocytes from the outbred CFl population is shown in Figure 20. The re­
sults indicate that H-2 antigens are detectable on embryos at all stages 
of development and on oocytes, and that the H-2 antigen per embryo in­
creases during development. Previously, the earliest cleavage stage shown 
to express H-2 antigens (heavy chain) had been the 8 cell stage (see Table 
3). The amount of H-2 per "outside" cell seems to decrease from the one 
cell to the two cell stage, and then remain constant (Table 5 and Figure 
21). However, electron microscopic studies, using immunoperoxidase 
labeling (Searle et al., 1976; Warner and Spannaus, 1984) have shown that 
the H-2 concentration in the trophectoderm of blastocysts is at least as 
high as that on 8 cell stage embryos, and quite a bit higher than the 
amount on 2-cell embryos. The reason for the discrepancy in these results 
is unclear. We have assumed that the ELISA reagents were accessible to 
only "outside" cells, but perhaps this is not true. 
The high expression of H-2 antigens by the oocytes confirms the ear­
lier immunofluorescent studies of Heyner and Hunziker (1979). The higher 
expression is probably due to maternal mRNA present in the cytoplasm. No 
studies have yet reported maternal versus paternal H-2 antigen expression 
in one cell embryos. A number of studies have shown that the embryo's own 
genes are not expressed until the 2 cell stage (Wudl and Chapman, 1976; 
Warner and Hearn, 1977; and Sawicki et al., 1981). The expression of H-2 
antigens on one cell stage embryos is also high and may be a result of 
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oocyte contamination, as it is difficult to separate fertilized from un­
fertilized eggs. 
The expression of individual class I antigens was followed with anti­
gen specific monoclonal antibodies. The ontogeny of H-2Kk antigens on 
BIO.BR embryos was followed with embryo ELISA II and the 11-4.1 (anti-H-
2Kk) monoclonal antibody. This antibody is specific for the H-2Kk anti­
gen, which is expressed on cells, as shown in Figure 21b. The antibody 
was apparently specific for embryos at a 1:10 dilution, as shown in Figure 
22. The reason for the apparent crossreactivity on embryos at a 1:5 dilu­
tion is unknown. The results illustrated in Figure 23 show that the H-2Kk 
antigen is detectable at low levels on embryos of all stages of develop­
ment studied and on oocytes, and that the amount of H-2Kk antigen per 
embryo is constant from the 2 cell to 8 cell stage before increasing. 
When these results are calculated on a per "outside" cell basis (Figure 
24), the expression of H-2Kk antigens decreases from the oocyte to the 2 
cell stage and then levels off. These results are similar to those seen 
for all H-2 antigens (compare Figures 21a and 24a). 
The expression of H-2Kb antigens on C57BL/6 embryos was followed 
using embryo ELISA II and monoclonal antibody, B8-24-3. This monoclonal 
antibody was thought to be specific for the H-2Kb antigen, but was shown 
to crossreact with H-2k antigens on cells (Figure 24b) and embryos (Figure 
25a). The B8-24-3 cell line was created by the fusion of spleen eels from 
a BALB/c (H-2d) mouse, which had been injected with EL-4 (H-2^) cells, and 
SP2/0 cells (Kohler et al., 1981). The H-2k and H-2b haplotypes share one 
antigenic specificity after absorbation of the H-2^ haplotype by the H-2^ 
haplotype. The shared specificity could cause the crossreactivity of the 
B8-24-3 monoclonal antibody with the H-2k haplotype. On embryos, the 
crossreactivity seemed to be at a minimum at a 1:10 dilution so the ex­
periments were continued. Figure 25b shows a titration curve of the B8-
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24-3 monoclonal antibody on C57BL/6 embryos. Little reaction with the 
unrelated monoclonal antibody, N-S.8.1, suggests that the binding of the 
B8-24-3 antibody to embryos is not totally nonspecific. The ontogeny of 
the H-2 antigens on C57BL/6 embryos detected by B8-24-3 monoclonal anti­
body is shown in Figure 26. The results indicate a low level of expres­
sion on oocytes, similar to expression on 2 cell and 8 cell embryos. 
Expression on blastocysts seems to be at a somewhat higher level, but may 
not be real because of the large degree of error seen. When the absorb-
ances were calculated on a per "outside" cell basis, the amount of H-2Kb 
antigen apparently decreases from the oocyte to the 2 cell to the 8 cell 
stage and then levels off (Figure 27). The "outside" cells of two cell 
stage embryos appear to express a high level of H-2Kb antigen; this result 
is in direct contrast to the expression of total H-2 and H-2Kk antigens by 
two cell stage embryos (compare Figures 21a and 24a with Figure 27). 
While the results in Figure 26 and Table 9 seem to indicate expression of 
the H-2Kb antigen by C57BL/6 embryos, it is difficult to interpret the 
results because of the high degree of error seen at some points. The 
crossreactivity of the antibody also poses questions as to what antigens 
are being detected. In order to determine the nature of H-2b antigen 
expression by C57BL/6 embryos, these experiments should be repeated with a 
second monoclonal antibody, specific for H-2b antigens, that does not 
exhibit crossreactivity with antigens of other haplotypes. 
The ontogeny of the Qa-2 antigens was followed using a monoclonal 
antibody specific for the Qa-2 antigen. This antibody does not crossreact 
with any known H-2K or H-2D antigens. The results in Figure 33 show that 
the amount of Qa-2 antigen is low on oocytes and increases dramatically 
from the 2 cell to the blastocyst stage of development. When these re­
sults are calculated on a per "outside" cell basis (Figure 34), it is seen 
that the amount of Qa-2 antigen doubles from the 8 cell to blastocyst 
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Stage of development. This result is in marked contrast to the results 
shown in Figures 21a, 24a and 27, which show that total H-2, H-2Kk and H-
2Kb class I antigens are expressed equally (per "outside" cell) by 8 cell 
and blastocyst stage embryos. 
The expression of class II molecules during development was followed 
using a monoclonal antibody specific for la molecules, YP-3. Figure 36 
shows the expression of class II molecules on CFl embryos. The expression 
of class II molecules appears to decrease from the oocyte to 1 cell stage, 
then increases from the 1 cell to two cell stage, decreases slightly at 
the 8 cell stage, and then increases markedly at the blastocyst stage. 
The amount of antigen per "outside" cell is shown in Figure 37. These 
results indicate that class II antigen expression decreases from the oo­
cyte to one cell stage and is then fairly level throughout development. 
However, the low absorbances observed for all stages except the blastocyst 
stage and oocytes may indicate negative results for the other develop­
mental stages. Expression of class II antigens by oocytes is probably a 
reflection of maternal antigen expression, as discussed earlier. 
The expression of the paternal genome in blastocyst stage embryos was 
detected by determining the H^^ type of (BIO.BR? x B10(f)Fi and (B10$ x 
B10.BRef)Fi blastocyst stage embryos. The results in Figure 38 indicate 
that maternal and paternal antigens are expressed on blastocyst stage 
embryos. These results support the findings of Sawicki et al. (1981) and 
Wudl and Chapman (1976) who were able to detect paternal genome expression 
at the 2 cell stage of development. We have been unable to collect con­
clusive results on the expression of the paternal H-2 haplotype by earlier 
stage embryos than the blastocyst stage. As stated before, the results 
with the 11-4.1 monoclonal antibody seem certain, but the results with the 
88-24-3 monoclonal antibody are suspect due to the unexpected crossreac-
tion seen in Figure 24b. 
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Table 26. Summary of MHC antigens expression by blastocyst stage 
embryos 
ELISA Results 
Mean A410 per 
Monoclonal Antibody outside" 
Strain Designation Concentration Specificity Embryo Cell 
CFl Ml/42 O.lmg/ml* all H-2 
class I 
0.070 0.004 
BIO.BR 11-4.1 O.lmg/mlB H-2Kk 0.070 0.006 
C57BL/6 B8-24-3 O.lmg/mia H-2Kb 0.053 0.004 
CFl D3.262 _b Qa-2a 0.550 0.029 
CFl 18/20 _b TL 0.000 0.000 
CFl YP-3 0.41mg/ml& all H-2 
class II 
0.037 0.002 
(except H-2d) 
® Prepared by salt-cut from ascites as described in Materials and 
Methods. 
b These monoclonal antibodies were used as ascities fluid, therefore, 
it is not possible to determine the exact antibody concentration. 
A comparison of the relative levels of antigen expression by blas­
tocyst stage embryos can be made from the summarized values shown in Table 
26. The amount of total H-2, H-2Kk, and H-2Kb expressed appear to be 
similar, but the amount of Qa-2 antigen expressed by embryos seems to be 
considerably higher. Recent evidence has shown that the expression of 
individual class I molecules is regulated independently (King et al., 
1985). This finding appears to be supported by the differences seen in 
total H-2 and Qa-2 antigen expression. The results in Tables 5, 7, 9 and 
11 indicate that 2 cell and 8 cell stage embryos express low levels of H-2 
antigens and higher levels of Qa-2 antigens. The expression of class I 
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antigens by 2 cell stage embryos has not been previously reported (see 
Table 3), although S2 microglobulin has been detected on 2 cell stage 
embryos (Sawicki et al., 1981). 
The suggestion that embryos express greater amounts of Qa-2 antigen 
than H-2 antigens is intriguing because adult cells express between 10 and 
50 fold less Qa-2 than H-2. This may suggest that Qa-2 antigens play a 
role in development. However, these observation are qualitative; quan­
titative comparisons can only be made when the affinity and valency of 
antibody binding is known. The Qa-2 antigen was detected with an IgM 
monoclonal antibody, whereas the other antigens were detected with IgG 
monoclonal antibodies. Thus, it is uncertain whether the apparently 
higher Qa-2 than H-2 antigen expression is due to the valency of the anti­
body, or to increased amounts of Qa-2 on the cell surface compared to H-2. 
This problem could be resolved by using antibodies of known valency and 
affinity. 
Greenbury et al. (1965) have shown that monovalent and divalently 
bound states of the IgG antibody can co-exist in equilibrium with each 
other on the cell surface. Thus, the relative amounts of antigens de­
tected with IgG monoclonal antibodies is also uncertain. Dower et al. 
(1984) have developed a means for determining the valency and affinity of 
IgG antibodies binding to cell surface components. The method involves 
equilibrium and kinetic analyses of the binding of radiolabeled monoclonal 
antibodies to spleen cells. Using this technique. Dower and colleagues 
were able to determine the binding mechanisms for two monoclonal anti­
bodies, 37-7-5 (anti-H-2Kk) and 27-11-13 (anti-H-2Db/d). Studies are 
underway in our laboratory to measure the level of antigen expression by 
embryos with these antibodies. 
What mechanism prevents the maternal immune system from rejecting the 
embryo? Some workers (reviewed by Beer and Sio, 1982) have suggested that 
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immunologic immaturity and a lack of MHC antigen expression enables the 
embryo to evade the maternal immune system and avoid rejection. However, 
the results discussed above show that blastocyst stage embryos express 
both maternal and paternal MHC antigens (Figure 38), and that the level of 
MHC antigen expression per embryo increases at the blastocyst stage (see 
Figures 20, 27, and 33). This increase is especially interesting as this 
is the stage at which implantation occurs. Thus, other mechanisms must be 
involved in maternal-fetal tolerance. 
Recent evidence has shown that class I antigen modulation is involved 
in the ability of certain tumors to escape inmune surveillance (reviewed 
by Goodenow et al., 1985). Some of the same mechanisms that allow tumor 
cells to evade the host immune system may be active in embryonic cells. 
As in tumor cells, the modulation of individual class I antigen expression 
in early embryos may function as a means of evading the maternal immune 
system. In addition, some class I molecules appear to be involved in 
tumor localization and implantation (Simonsen et al., 1985). H-2 antigens 
may also facilitate embryo localization and implantation. 
The expression of H-2 antigens by embryos was confirmed by blocking 
studies. When BIO.BR (H-2k) embryos were incubated with 11-4.1 (anti-H-
2Kk) monoclonal antibody, in the presence of purified H-2Kk antigen, the 
binding was shown to be 68% less than antibody binding in the absence of 
antigen (Table 24). These findings confirm the presence of H-2 antigens 
on early embryos. The antigen also reduces the binding of B8-24-3 (anti-
H-2Kb) monoclonal antibody to BIO.BR embryos by 292 and C57BL/6 (H-2b) 
embryos by 33%. This reduction is explained by the crossreactivity of the 
antibody with the H-2k haplotype (see Figure 24b and 25). It appears that 
some binding of antibody to the embryos is nonspecific. The nonspecific 
binding of antibodies to embryos may be due to the expression of Fc re­
ceptors on the embryo cell surface. This hypothesis was first proposed by 
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Warner et al. (1985b) as a means of explaining residual killing of embryos 
by absorbed antisera. The binding of antibodies by Fc receptors expressed 
on the embryo cell surface could result in false reports of H-2 antigens 
on early embryos. It is possible that the low levels of expression of H-2 
antigens seen in 2 cell and 8 cell stage embryos are due to Fc receptor 
binding of the antibody. However, there is no reason to suspect that the 
Fc receptors would bind H-2 specific antibodies with a greater affinity 
than control antibodies, so there is every reason to believe that most of 
the binding detected with the monoclonal antibodies was via the antigen 
binding site. It would be interesting to determine if embryos do express 
Fc receptors. It would also be interesting to use Fab fragments from the 
antibodies for binding studies. 
Previous studies of H-2 antigen expression on embryos have concen­
trated on the detection of antigens on the cell surface. An extremely 
important question is whether the H-2 antigens are cytophilically adsorbed 
to the surface of the embryos, or if they are synthesized by the embryos 
themselves. The results given in Figure 41 clearly show that embryos can 
be stripped of their H-2 antigens by papain, and can then regenerate the 
antigens after further incubation. Thus, there is no question that H-2 
antigens are synthesized by the embryos themselves. The embryos show 
results similar to cells in tissue culture, except that the maximum re­
covery is only about 60%, compared to 95% for the tissue culture cells. 
This could be due to differences in the rate of H-2 synthsis between both 
cell types, one being a transformed cell line (P815) and the other being 
normal embryonic cells. This is in agreement with the slow regeneration 
time observed in our studies. 
An interesting contrast to the results with papain, which specif­
ically acts on proteins with globular domains, such as H-2 antigens or 
immunoglobulins, are the results with pronase. Pronase removes all cell 
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surface proteins, regardless of conformation. The generalized removal of 
cell proteins by pronase versus the specific removal of cell proteins by 
papain is highlighted by comparing the results in Figures 40 and 41. Also 
of interest is the inability of embryos to regenerate H-2 antigens after 
removal with pronase, as shown in Figure 41B. This may be due to the 
higher proteolytic activity of pronase, compared to papain. 
Mapping of the Fed Gene 
The Fed gene is an H-2 complex associated gene which controls the 
rate of early embryo development. Segregation studies in this disserta­
tion indicate that the Fed gene is linked to the H-2 complex because the 
allele for slow development segregates with the H-2k haplotype in back-
cross generations (Figures 42 and 43). 
Mapping studies show that the Fed gene maps to the Qa-2 subregion of 
the mouse MHC (see Table 17). Qa-2 antigens are expressed on embryos 
possessing the fast Fed allele (Figure 29). These facts suggest that the 
Fed gene product may be the Qa-2 antigen. 
Incubation of 8 cell stage embryos with an anti-Qa-2 antibody 
(03.262), results in an inhibition of by ^H-thymidine incorporation at low 
serum dilutions and an enhancement at higher serum dilutions (Figure 44). 
The data in Figure 44 were collected in 3 experiments (see Table 21). The 
anti-Qa-2 monoclonal antibody and the control monoclonal antibody, N-S.2.1 
(anti-sheep red blood cells) were purified by ammonium sulfate precipita­
tion. Both antibodies are of the IgM class. These similarities in anti­
body preparation and isotype indicate that the effect seen in Figure 44 is 
probably specific for the Qa-2 antigen. A similar antiserum inhibition 
study has been done by Kemler et al. (1977) for the F9 antigen. In this 
study, compactation to the morula stage was affected without inhibiting 
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cleavage rate (Kemler et al., 1977). Further experimentation is needed in 
order to determine more precisely the effect of anti-Qa-2 antiserum on 
development. 
Flaherty (1980) has suggested that Q/TL antigens are expressed during 
different stages of lymphocyte differentiation. It is possible that class 
I molecules have evolved for different types of cell-cell recognition, 
with H-2D and H-2K functioning specifically in imune related reactions, 
and Q/TL functioning in development and differentiation. Boyse (1985) has 
suggested that the function of class I H-2 products in immunological mech­
anisms are elaborations of previous functions in development, Boyse sug­
gests that the Q/TL antigens may be the ones particularly involved in 
development. The work reported in this thesis supports this hypothesis. 
It seems that the presence of Qa-2 antigens is required for embryos to 
have a normal rate of cell division. It is possible that these molecules 
facilitate cellular aggregation and division during development, and that 
in the absence of Qa-2 antigens, the process is slower. Thus, it is 
fitting that the fast fed allele is found only in Qa-2+ strains and the 
slow Fed allele in Qa-2" strains. 
The ^  region contains a large array of genes, 10 in the C57BL/10 
(810) strain and 8 in the BALB/c strain (see Figure la). Only a few of 
the protein products of these genes have been elucidated. A structural 
change in the 5^/6^ region of the cluster 1 DNA segment of the BALB/c, 
which is equivalent to the Q6b/Q7b gene segment of the BIO, results in a 
change in Qa-2 phenotype from Qa-2+ to Qa-2". Recent data suggest that 4 
genes, Q6 to  ^code for antigens which are recognized by anti-Qa-2,3 
antisera (Mellor et al., 1984). Analysis of restriction fragment length 
polymorphisms have shown that some Qa-2" strains lack DNA corresponding to 
this region (Flaherty et al., 1985). The complete elucidation of the 
sequence of the DNA in these regions should help define the relationship 
160 
of the Fed gene product to the Qa-2 antigen. 
The genes of the Qa-2 subregion are highly regulated. Strains ex­
pressing Qa-2 antigens can be divided into high and low expressors 
(Michaelson et al.. 1981). This quantitative regulation seems to be af­
fected by other genes within the MHC (Michaelson et al., 1981) and affects 
other Qa-2 family members (Hairanerling et al., 1979). The Qa-2 gene ap­
pears to control the expression of other antigens encoded in this region. 
Expression of the Qa-3, Qa-5 and Qa-6 antigens Is dependent of Qa-2 ex­
pression. In light of this, it is possible that the Qa-2 subregion con­
trols an undefined region of the genome that contains the Fed gene, and 
that expression of the Fed gene product is dependent on Qa-2 expression. 
Thus, there are two different models for the role of Qa-2 antigens in 
early development, and the relationship of these molecules to the Fed 
gene. In the first model, the Qa-2 antigen is proposed to be the actual 
Fed gene product, and that as such these antigens would be directly in­
volved in the development and differentiation process. This model is 
supported by the mapping and linkage data reported here. The second model 
proposes that the Qa-2 molecule acts as a control molecule, regulating the 
expression of the Fed gene product. The Fed gene would then be located 
outside the Qa-2 subregion, but elsewhere in the MHC. 
The T/t complex, located 13.5 cm to the centromeric side of the H-2 
complex (Vitteta and Capra, 1978), has been proven to influence develop­
ment (Artz and Bennet, 1975). A t haplotype Is a structurally variant 
genomic region that contains a number of loci that cause abnormalities in 
sperm cell function or embryonic development (Silver et al., 1984). Some 
of these mutations cause death at the morula stage of development, others 
at 6, 9, 12, or 14 days of gestation. Others cause male sterility. Re­
cent evidence has shown that some t haplotypes contain inversions (Figure 
51), so that several t-lethal genes are located within the MHC (Shen et 
Mouse Chromosome 17 
Region TL (Q) D I K 
o-
w18 .lubi r'°i 
jw32 
t ! ' t 
j12 |W5 
Figure 52. Genetic organization of the Vh2 complex in t haplotypes. The Inversion of the re­
gions is shown; the brackets around the g region indicate that its exact location has 
not been determined. The location of the t lethal genes are shown. The precise 
positions of tLyk 1 and tiîlâ are not known; their general location is indicated by the 
double headed arrow 
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al., 1983). The lethal is very close to the H-2K region, t^^ and tw32 
are in the £ region, and and t^-ub-l are close to the H-2D region on 
the proximal side, although their exact position relative to Q/TL is not 
defined. Wild type chromosomes probably have the same relative genetic 
organization, and wild type alleles of the Jt-lethals seem to be certainly 
tightly linked to the H-2 complex (Shen et al., 1983). These findings 
raise the intriguing possibility that the Fed gene and the t-alleles may 
somehow be related. 
Are there Fed genes in other species? While there has been no direct 
evidence for such genes, numerous observations suggest that they exist. 
The best studied case is that of the pig. The female pig ovulates 15 to 
25 eggs, almost all of which are fertilized. Of these embryos only 50% 
remain 30 days later. A large range of development stages are seen in a 
single uterine horn (Anderson and Parker, 1976; Anderson, 1978). Recent 
date suggest that those embryos which are most advanced in their develop­
ment are the ones most likely to survive to term (Wilmut et al., 1985; 
Fope and First, 1985). In addition, studies have shown an association of 
the SLA complex with reproduction (Rothschild et al., 1984). While there 
are certainly environmental and genetic components, these findings hint at 
the existence of a MHC-linked Fed gene in the pig. 
There is a growing amount of evidence showing that the human MHC, the 
HLA complex, could be related to development. The HLA complex has been 
shown to be involved in recurrent spontaneous abortion by some groups 
(Scott, 1982; Singh and Gambel, 1982; and Bolis et al., 1985), but not by 
others (Caudle et al., 1983; Fersitz et al., 1985). Ober et al. (1985) 
have suggested that HLA-1inked genes play a potentially important role in 
normal pregnancy. It is inviting to propose that Fed genes associated 
with the HLA complex exist in the human population. Further support for 
this hypothesis comes from the work of Mohr and Trouson (1984) which shows 
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that rapidly dividing human embryos have a better potential to result in 
successful pregnancies. 
The study of the control of the rate of early embryonic development 
has several practical applications. In humans, embryos fertilized in 
vitro must be transferred to pseudopregnant mothers at the correct time in 
order to insure a successful pregnancy (Steptoe et al., 1980). Knowledge 
of the factors that control the rate of early development could have con­
siderable value in human fertility studies, as well as in studies on ab­
normal fetal development. 
Conclusions 
In summary, this work has shown that early mouse embryos express MHC 
antigens and that these antigens are synthesized by the embryos them­
selves, not cytophilically bound to the cell surface. These studies were 
possible because we were able to develop a highly sensitive method (embryo 
ELISA), to detect cell surface molecules on embryos. The results here 
also show that the Fed gene is linked to the H-2 complex and maps to the 
Qa-2 subregion. The fact that embryos with the fast Fed allele express 
Qa-2 antigens whereas embryos with the slow Fed allele do not, coupled 
with the mapping and linkage studies, have led us to propose two models 
for the involvement of Qa-2 antigens in development, one direct and one 
indirect. Studies are underway to determine which of these models is 
correct. 
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